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Cortical pyramidal neurons have exquisite morphology and electrophysiological 
properties, and elucidating how these features develop and are maintained is essential to 
understanding the physiological development of the central nervous system (CNS). The 
secreted semaphorins Sema3A and Sema3F have remarkably distinct effects on the 
development of deep layer cortical pyramidal neurons. Specifically, Sema3A promotes 
the elaboration of basal dendrites whereas Sema3F constrains spine density. This 
remarkable functional divergence implicates Sema3A and Sema3F, and their distinct 
holoreceptor complexes, in the establishment of neuronal architecture. However, the 
molecular mechanisms by which neuropilins, the secreted semaphorin ligand binding 
subunits of the Sema3A and Sema3F holoreceptors, exert their effects are largely 
unknown. Here, I demonstrate that the two Npns, Npn-1 and Npn-2, are S-palmitoylated 
in cortical neurons and in the mouse brain. Interestingly, Npn-1, which binds Sema3A, 
and Npn-2, which binds Sema3F, exhibit distinct cell surface distribution patterns; Npn-2 
is clustered whereas Npn-1 is diffusely distributed. Importantly, inhibition of Npn-2 
palmitoylation abolishes Npn-2 clustering whereas it does not affect Npn-1 localization. 
These data suggest that palmitoylation conveys to Npn-2, but not Npn-1, a distinct 
localization pattern and, possibly, function. I therefore investigated the role of 
palmitoylation in Npn-2 localization and function. I demonstrate that mutation of the 
membrane-proximal Npn-2 cysteines abolishes the ability of Npn-2 to mediate spine 
constraint in response to Sema3F and causes profound defects in Npn-2 distribution and 
trafficking in cortical neurons. On the contrary, C-terminal Npn-2 cysteine residues are 
dispensable for these effects. Thus, there is a strong functional segregation within the 
	 iii 
Npn-2 structure regarding cysteine residue functions. Interestingly, Npn-1 and Npn-2 
serve as substrates for distinct palmitoyl acyltransferases. The palmitoyltransferase 
DHHC15 is involved in Sema3F/Npn-2–induced spine constraint, whereas it is not 
required for Sema3A/Npn-1–mediated dendritic elaboration of deep layer cortical 
neurons. On the other hand, the palmitoyltransferase DHHC8 is apparently indispensable 
for Sema3A/Npn-1–mediated dendritic elaboration but not for Sema3F/Npn-2–induced 
spine constraint. These observations are in accordance with biochemical and genetic 
experiments showing that DHHC15 and DHHC8 have distinct substrates. 
Palmitoyltransferase substrate specificity, therefore, plays critical roles in establishing 
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Neurons are polarized cells, facilitating the performance of specialized functions by 
different regions of the same cell. Unique combinations of dendritic and axonal 
morphologies regulate synaptic properties and coordinate neural transmission within 
circuits. Factors that affect complexity of dendritic arbors have a profound influence on 
the number and type of synaptic inputs a neuron receives (Spruston, 2008). Dendrites of 
many neurons exhibit small protuberances called spines; these are the sites of excitatory 
synaptic transmission. A growing number of molecules are now known to affect 
excitatory synapse formation in the mammalian central nervous system (CNS), including 
transmembrane proteins and also secreted proteins that can be derived from neurons or 
astrocytes (Dalva et al., 2007; Eroglu and Barres; Mcallister, 2007). Recent work shows 
that members of the semaphorin protein family, too, play critical roles in establishing 
neural connectivity and regulating synaptic development and function.  
We consider here recent work showing how semaphorins regulate neuronal 
polarization, multiple aspects of dendritic morphology, excitatory and inhibitory 
synaptogenesis, and the establishment of precise connectivity among disparate neuronal 
classes. Following these initial stages of synapse formation, many axonal and dendritic 
circuit components are refined, or pruned, to generate mature circuits, and some of these 
events involve semaphorin signaling. Modulation of synaptic transmission provides 
neural circuits with the potential for experience-dependent plasticity, and recent work 
suggests that semaphorin signaling functions throughout life to sculpt circuits in response 
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to experience. Together, all of these observations expand our view of the molecular 
landscape that influences neural circuit elaboration, uncovering novel influences on 
synapse development, function, and plasticity. 
 
Semaphorins regulate neuronal polarity, dendritic arborization, and synapse 
distribution  
	
The complexity of dendritic arbors greatly influences neuronal electrical properties. 
Ample evidence shows that semaphorin signaling affects the development of dendrites 
belonging to multiple and diverse neuronal classes. The Class 3 secreted semaphorin 
Sema3A promotes dendrite development with a concomitant inhibition of axon growth in 
vitro (Nishiyama et al., 2011; Shelly et al., 2011). Further, Sema3A promotes the 
elaboration of cortical layer 5 pyramidal neuron basal dendrites during postnatal mouse 
development (Gu et al., 2003; Tran et al., 2009) and also dendritic development in newly 
born adult dentate gyrus (DG) granule cell (GC) (Ng et al., 2013). Therefore, molecular 
programs that regulate dendritic development are likely conserved from embryogenesis to 
the adult. 
In highly stratified regions of the nervous system, where synaptic specificity is 
achieved through neurite arborization of select neuronal populations in precisely defined 
layers, semaphorins function to constrain dendritic arbors within laminae. In the Xenopus 
retina, class 3 semaphorins regulate asymmetric growth of retinal ganglion cell (RGC) 
dendritic arbors (Kita et al., 2013). In the mouse retina, the transmembrane semaphorins 
Sema6A, Sema5A and Sema5B direct precise neurite patterning of select retinal cell 
types  (Matsuoka et al., 2011a, 2011b; Sun et al., 2013). In the Drosophila visual system, 
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transmembrane Sema-1a guides growing L3 neuron axons to their laminar target in the 
M3 layer of the medulla (Pecot et al., 2013). Sema-1a also acts in the Drosophila 
olfactory system to pattern the dendrites of olfactory projection neurons within the 
antennal lobe (Komiyama et al., 2007), responding to a gradient of the secreted 
semaphorins Sema-2a and Sema-2b in the dorsolateral antennal lobe (Sweeney et al., 
2011).  
 Semaphorins also influence synapse formation and subcellular synaptic 
localization. In C. elegans two transmembrane semaphorins, Sema-1 and Sema-2, which 
signal through the plexin-1 receptor, act to restrict en passant synapse formation between 
complementary axonal regions of two adjacent motor neurons in the same muscle field 
(Mizumoto and Shen, 2013). Further, in the mouse cerebral cortex the secreted 
semaphorin Sema3F regulates subcellular synapse specificity by constraining dendritic 
spine density selectively along apical dendrites of deep layer pyramidal neurons (Tran et 
al., 2009) (Figure 1a).  
  
Pathway-specific connectivity: semaphorins and the CNS circuit development 
	
During neural circuit assembly, growing axons recognize their postsynaptic partners and 
make appropriate synaptic contacts. The circuits that define spinal reflex arcs mediate 
spinal motor responses to specific sensory input and exhibit remarkable synapse 
specificity within the spinal cord. In the sensory-motor reflex arc of the cutaneous 
maximus (Cm) muscle, chemorepulsive signaling mediated by Sema3E-plexin-D1 is 
critical for preventing the formation of monosynaptic inputs between Cm proprioceptor 
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sensory neurons and Cm motor neurons; numerous aberrant monosynaptic inputs occur in 
the absence of this signaling pathway (Pecho-Vrieseling et al., 2009). However, even in 
the absence of Sema3E, Cm motor neurons still receive input only from Cm afferents and 
not triceps (Tri) muscle afferents (another spinal reflex circuit), and Cm afferents do not 
form ectopic contacts with Tri motor neurons. At lumbar spinal cord levels, Sema3E-
plexinD1 signaling also acts to prevent the formation of aberrant monosynaptic 
connections between specific sensory afferents and motor neurons of functionally non-
related muscles, thereby controlling monosynaptic sensory-motor innervation of 
appropriate motor neuron pools (Fukuhara et al., 2013).   
Sema3E-PlexinD1 signaling is also a critical determinant of specific connectivity 
in the thalamostriatal “direct” basal ganglia pathway. Sema3E, which is expressed and 
secreted by the axons of thalamostriatal neurons, binds its receptor plexinD1, which is 
selectively expressed by the direct pathway medium spiny neurons in the striatum. 
Sema3E-plexinD1 repulsive signaling acts to constrain synapse formation between the 
thalamostriatal neurons and the striatal medium spiny neurons of the direct pathway 
(Ding et al., 2012). Taken together, Sema3E-plexinD1 signaling in the CNS mediates 
several critical aspects of cell type- and pathway-specific connectivity.  
 
Semaphorins regulate excitatory and inhibitory synaptogenesis  
	
Semaphorins function as regulators of synapse formation, independent from their roles in 
guiding axonal and dendritic projections. This was initially suggested in Drosophila by 
work showing that the transmembrane semaphorin Sema-1a is critical for the formation 
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of the giant fiber central synapse in developing pupae (Godenschwege et al., 2002). In 
mammals, Sema3F–neuropilin-2 signaling apparently alters the balance between 
excitation and inhibition in the mouse cerebral cortex (Tran et al., 2009) and in the 
hippocampus (Sahay et al., 2005) by selectively constraining excitatory synapse 
formation. A similar role in hippocampal synaptic transmission has also been 
demonstrated for Sema3A (Bouzioukh et al., 2006). The transmembrane semaphorin 
Sema5B reduces synapse number in cultured hippocampal neurons (O’Connor et al., 
2009), whereas Sema5A constrains glutamatergic synapse development on dentate gyrus 
granule cells (Duan et al., 2014; O’Connor et al., 2009). Other semaphorins facilitate 
excitatory synapse formation in cultured hippocampal neurons. The class 4 
transmembrane semaphorin Sema4B promotes the formation of excitatory synapses in 
cultured hippocampal neurons (Paradis et al., 2007) (Figure 1a). Interestingly, class 4 
semaphorins, including Sema4B, can interact with PDZ domain-containing proteins such 
as PSD-95 when co-expressed in vitro (Burkhardt et al., 2005; Inagaki et al., 2001; 
Schultze et al., 2001), however the relevance of this interaction to synapse formation has 
not been determined. 
Unlike excitatory synaptogenesis, the formation and maintenance of inhibitory 
synapses is much less well understood. Certain class 4 semaphorins are important 
regulators of inhibitory synaptogenesis. Sema4B promotes inhibitory synapse formation 
through effects on the maturation of postsynaptic specializations, similar to its role at 
excitatory synapses (Paradis et al., 2007) (Figure 1b). Furthermore, the closely related 
Sema4D is enriched at synapses and exclusively promotes the assembly of inhibitory 
synapses in hippocampal neurons, requiring the plexin-B1 receptor (Kuzirian et al., 2013; 
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Paradis et al., 2007; Raissi et al., 2013) (Figure 1b). Interestingly, exogenously supplied 
Sema4D in vitro suppresses epileptiform activity observed in organotypic hippocampal 
slices following TTX withdrawal. Taken together, these results show that Sema4D 
induces the formation of functional GABAergic synapses (Kuzirian et al., 2013). 
 
Semaphorin-mediated synapse elimination  
	
Though numerous signaling pathways regulate neural circuit assembly (Winberg et al., 
1998), these are not sufficient to prevent the formation of ectopic synapses (Innocenti and 
Price, 2005). To achieve precise nervous system wiring aberrant axonal tracts must be 
withdrawn, a process known as pruning, and excess synapses eliminated (Riccomagno 
and Kolodkin, 2015). Removal of aberrant synaptic specializations can occur along with, 
or independent of, axon pruning. Axonal trajectories destined to be pruned often are 
associated with pre- and postsynaptic specializations (Liu et al., 2005; Low et al., 2008; 
Riccomagno et al., 2012). For example, during the pruning of the mouse hippocampal 
infrapyramidal tract (IPT), a mossy fiber projection normally pruned postnatally by 
Sema3F (Bagri et al., 2003), the Rac GTPase-activating protein (GAP) β2-chimaerin 
inactivates Rac1 to induce pruning (Riccomagno et al., 2012). IPT pruning is 
accompanied by the loss of presynaptic specializations formed earlier between the IPT 
axons and CA3 pyramidal dendrites. Interestingly, β2-chimaerin–mediated signaling is 
not required for Sema3F-mediated dendritic spine constraint or repulsive axon guidance, 
demonstrating that different Sema3F/Nrp-2–PlexA3 signaling modalities are engaged to 
regulate distinct aspects of neural wiring.  
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Regulation of semaphorin signaling by neuronal activity 
	
During early stages of neural circuit maturation, neurons can simultaneously respond to 
guidance cues and patterns of activity (Shen et al., 2010; Greer et al., 2008). Therefore, 
electrical and guidance cue stimuli might converge to regulate synaptogenesis. This idea 
was addressed in vitro by showing that electrical activity modulates neuronal responses to 
chemotropic molecules (Ming et al., 2001; Nicol et al., 2007). A fairly recent study 
demonstrates an in vivo role for such modulation at the Drosophila neuromuscular 
junction (NMJ) (Carrillo et al., 2010). Embryonic and larval body wall muscles secrete 
Sema-2a, a chemorepellent that signals through the Plexin B receptor to regulate motor 
axon guidance and neuromuscular connectivity (Ayoob et al., 2006). Electrical activity in 
PlexB-expressing motor neurons enhances motor neuron responses to the muscle-derived 
Sema-2a, and this modulation of Sema-2a signaling requires an increase in calcium entry 
at the presynaptic terminal. Calcium entry in turn activates CaMKII, likely leading to the 
phosphorylation of downstream targets and subsequent increased sensitivity to Sema-2a. 
Genetic interaction experiments reveal numerous ectopic motor axon-muscle contacts in 
the context of reduced presynaptic activity and Sema-2a levels, showing that activity-
induced enhancement of Sema-2a signaling in motor neurons is required for synaptic 
target selection (Carrillo et al., 2010) (Figure 2). These results define a regulatory 
mechanism that exerts spatial and temporal control over chemorepulsion, demonstrating 
how molecular and electrical stimuli can be integrated to precisely coordinate synapse 
refinement in vivo.  
 The expression patterns and functions of several semaphorins in the adult 
hippocampus (Sahay et al., 2005) raise the possibility that these cues signal later in 
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development, and even in the adult, to regulate synaptic strength in response to 
experience. This idea is supported by the demonstration that expression of neuropilin-2 
(Nrp-2), a secreted semaphorin co-receptor, is influenced by the activity-regulated 
microRNA-188 (miR-188). In response to long-term potentiation (LTP), miR-188 
expression increases, resulting in the downregulation of Nrp-2 expression and subsequent 
abolition of Nrp-2–mediated inhibition of excitatory synapse formation and synaptic 
transmission (Lee et al., 2012). It will be important to assess this mode of activity-
dependent regulation of semaphorin signaling in vivo. These results suggest that 
Sema3F–Nrp-2 signaling, and possibly other semaphorin signaling pathways, are also 




Semaphorins join an ever-growing list of synaptogenic and synapse-limiting molecules, 
and they have emerged as important regulators of excitatory and inhibitory 
synaptogenesis and function. This is of particular interest since the molecular 
mechanisms underlying inhibitory synapse formation are poorly defined, and it suggests 
semaphorins participate in regulating network properties by modulating the balance 
between excitatory and inhibitory synaptic functions.  
Semaphorin influences on synapse formation and function raise the possibility 
that these molecular cues are involved in the pathogenesis of disorders characterized by 
profound defects in synaptic transmission, including epilepsy and various cognitive 
disorders. Indeed, Sema3F and Sema4D influence neuronal activity in mouse epilepsy 
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models (Kuzirian et al., 2013; Sahay et al., 2005), suggesting potential targets for the 
development of novel therapeutic approaches directed toward ameliorating epilepsy 
symptoms. Since electrical activity can modulate semaphorin signaling in vivo, 
integration of semaphorin signaling and neuronal activity may provide for precise control 
of neuronal morphology, synaptogenesis, and plasticity throughout life. 
Despite that numerous studies have provided insight into the role semaphorins 
play in dendritic elaboration and dendritic spine development, the molecular mechanisms 
by which they regulate these aspects of CNS development have not been elucidated. 
Herein, we identify a post-translational modification of neuropilins that regulates 
neuropilin function and subsequently class 3 secreted semaphorin signaling in cortical 
neurons. We show that this modification critically controls proper dendritic spine density 
and distribution mediated by Sema3F/Npn-2 signaling and is also required for cortical 
neuron dendritic elaboration mediated by Sema3A/Npn-1 signaling. The specificity of 










Figure 1. Semaphorins directly affect synapse formation, altering the balance 
between excitation and inhibition.  
(a) Semaphorins and excitatory synaptogenesis. (I) Sema3F inhibits excitatory synapse 
formation by constraining the density of dendritic spines along apical dendrites of deep 
layer cortical pyramidal neurons. (II) Sema4B promotes the assembly of glutamatergic 
synapses in cultured hippocampal neurons. The Sema4B cytoplasmic domain includes a 
PDZ-binding motif that can associate with PSD-95, possibly mediating assembly of 
postsynaptic specializations (though this has yet to be demonstrated).  
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(b) Semaphorins and the assembly of inhibitory synapses. (I) Sema4D promotes 
GABAergic inhibitory synaptogenesis in hippocampal neurons in vitro and in vivo.  
Sema4D is required in postsynaptic neurons, where it is mainly localized to synapses, 
both in vitro and in vivo. However, plexin-B1 could act in cis (in the postsynaptic neuron) 
or in trans (in the presynaptic terminal) to mediate the assembly of inhibitory synapses. 
Posttranslational proteolytic Sema4D processing occurs in vitro and in vivo but 
apparently is not required for Sema4D regulation of GABAergic synapse assembly. (II) 














Figure 2. Electrical activity and chemotropism in synapse refinement in vivo.  
(a) In Drosophila embryos and larvae, electrical activity in motor neurons renders them 
	 13 
 more sensitive to the muscle-derived chemorepellent Sema-2a, causing exuberant motor 
neuron terminals to withdraw and preventing aberrant synapse formation at the 
Drosophila neuromuscular junction.  
(b) Null mutations in Sema-2a or (c) ion channels, allow motor neurons to establish 
ectopic synaptic contacts on somatic muscles that mature into functional synapses.  
(d) Electrical activity in motor neurons synergizes with the response to Sema2a, mediated 
by the plexin B receptor (expressed in motor neurons), and regulates formation of 
neuromuscular junctions. A partial loss of presynaptic activity accompanied by a partial 
loss of chemorepulsion leads to the formation of ectopic synaptic contacts on muscles. 
Therefore, electrical activity interacts with Sema-2a–Plexin-B chemorepulsive signaling 






























CHAPTER 2  
NEUROPILIN PALMITOYLATION REGULATES DISTRIBUTION AND 




The central nervous system consists of numerous disparate neuronal classes that exhibit 
remarkably different morphologies, including their dendritic arborization and the 
distribution of synapses formed onto them by their presynaptic partners. This is 
particularly prominent in layered structures such as the cerebral cortex and the retina. 
Cortical neurons are highly polarized and their morphology dictates to a major extent 
their computational properties (Spruston, 2008). However, the molecular codes that 
underlie such an outstanding degree of specificity are not well understood. There is an 
ever-growing list of proteins that regulate spine formation, synapse assembly and 
dendritic arborization, but the downstream effectors that make these proteins affect one 
or the other aspect of neuronal morphology are in most cases poorly defined. The 
elucidation of the molecular mechanisms that underlie proper spine formation is of 
critical importance given the association of dendritic spine defects with a number of CNS 
illnesses (Penzes et al., 2011). One class of protein that has been shown to regulate 
neuronal dendrites, spines and synapses is the semaphorins (Koropouli and Kolodkin, 
2014). Class 3 secreted semaphorins play critical roles in the development of neuronal 
morphology by regulating axon guidance (Giger et al., 2000), basal dendritic arborization 
(Gu et al., 2003) or spine distribution and synaptic transmission (Sahay et al., 2005; Tran 
et al., 2009). Additional semaphorins, and specifically Sema4B and Sema4D, have been 
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implicated in the regulation of inhibitory synapses (Kuzirian et al., 2013; Paradis et al., 
2007; Raissi et al., 2013). The molecular mechanisms that implicate different semaphorin 
signaling pathways in distinct aspects of cortical neuron morphogenesis are not known. 
Sema3A and Sema3F act through distinct holoreceptor complexes consisting of a 
neuropilin and a plexin; specifically, Sema3A acts through Npn-1/plexin-A4 (Kolodkin 
AL et al., 1997), whereas Sema3F exerts its effect via Npn-2/plexin-A3 (Chen et al., 
1997; Giger et al., 1998). The molecular mechanisms that regulate the trafficking and 
function of these receptors, conveying functional diversification and specificity in 
cortical neuron morphogenesis, remain to be elucidated. 
     Recent work on post-translational modifications of proteins within the nervous system 
reveals that the reversible post-translational modification S-palmitoylation critically and 
dynamically regulates the distribution and function of an increasing roster of neuronal 
proteins implicated in CNS development (Salaun et al., 2010). These include cues that 
influence dendritic arborization (Takemoto-Kimura et al., 2007), spine formation such as 
paralemmin (Arstikaitis et al., 2008; Kutzleb et al., 1998), CDC-42 (Kang et al., 2008) 
and LIM1-kinase (George et al., 2015), and axon outgrowth. Besides neural development, 
palmitoylation also occurs on numerous other proteins, including neurotransmitter 
receptors (Hayashi et al., 2005, 2009), gluatamate receptor-interacting proteins (Thomas 
et al., 2012) and cell adhesion molecules (Brigidi et al., 2014a). It is not surprising, 
therefore, that palmitoylation plays critical roles in synapse assembly and synaptic 
transmission (Fukata and Fukata, 2010). Importantly, palmitoylation can have slow or 
very fast turnover, and therefore it has the potential to dynamically regulate protein 
trafficking and function (Martin et al., 2011). In this study, we demonstrate that 
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neuropilins are S-palmitoylated both in vitro and in vivo, and we show that this 





Npn-1 and Npn-2 exhibit distinct cell surface distribution patterns  
	
To identify potential differences between Npn-1 and Npn-2, we first used a simple in 
vitro system, expression of proteins in transfected COS7 cells, to express and visualize 
the distributions of Npn-1 and Npn-2 on the cell surface. To this end, COS7 cells were 
transfected with amino-terminally (extracellular) flag-tagged Npn-1 or flag-tagged Npn-
2, and a few days later neuropilin protein was visualized with live staining using a flag 
antibody. Strikingly, Npn-1 is diffusely distributed (Figure 3, panel A), whereas Npn-2 
is clustered, appearing as numerous discrete puncta (Figure 3, panel D). This difference 
likely reflects a distinct tethering and partitioning of the two neuropilins into distinct 
domains in the cell membrane, although the identity of these domains has not been 
determined.    
 
Inhibition of palmitoylation abolishes Npn-2 clustering 
	
Our observations point toward some selective modification on Npn-2, which dictates its 
cell surface clustering. There is compelling evidence that palmitoylation conveys to 
proteins the capability to be strongly tethered on cell membranes (Shahinian and Silvius, 
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1995), leading to clustering on the surface of cell lines and neurons (El-Husseini et al., 
2002; Webb et al., 2000). To test the possibility that Npn-2 is clustered as a result of 
palmitoylation, we took a pharmacological approach by using 2-bromopalmitate, a global 
inhibitor of palmitoylation (Jennings et al., 2009; Resh, 2006). In collaboration with 
Sarah Mitchell (a research technician in the Kolodkin laboratory), we treated COS7 cells 
expressing amino-terminally flag-tagged wild type (WT) Npn-2 with 10 µM or 50 µM 2-
bromopalmitate for 6 hours, or overnight, and then visualized cell surface Npn-2 using 
live staining and the flag antibody (FLAG M2).  
     With the control treatment (DMSO, used here to dissolve 2-bromopalmitate), Npn-2 is 
clustered in the form of discrete puncta, suggesting that Npn-2 is localized in particular 
plasma membrane domains. Strikingly, in the presence of 2-bromopalmitate Npn-2 is 
distributed diffusely over the entire cell surface. Treatment with 10 µM 2-bromopalmitate 
for 6 hours caused a switch from Npn-2 being clustered to being diffuse in most cells, 
leaving only a few COS cells exhibiting clustered Npn-2 distribution. However, 
overnight treatment with 10 µM 2-bromopalmitate or treatment with 50 µM 2-
bromopalmitate, either for 6 hours or overnight, caused a complete shift from Npn-2 
clustering to diffuse cell surface distribution (Figure 3, panels E, F). Npn-2 distribution 
patterns obtained with live staining were quantified using a range of defined qualitative 
scoring parameters; these are: (1), rather diffuse (2), rather punctate (3) and punctate (4) 
distribution.  
     This finding is consistent with reports showing that 2-bromopalmitate treatment of 
cells causes a dispersion and/or diffusion of highly clustered proteins in cell lines (Webb 
et al., 2000) and neurons (El-Husseini et al., 2002). On the other hand, Npn-1 is diffusely 
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localized on the surface of COS7 cells in either the control treatment or any of the 2-
bromopalmitate treatments applied (Figure 3, panels A-C). These data suggest that 
proteins are diffusely localized in the absence of specific determinants, and that protein 
clustering requires additional and/or specific molecular events such as protein-protein 
interactions or other modifications to be selectively localized along the cell surface. 
Furthermore, the inhibition of Npn-2 clustering with a palmitoylation inhibitor suggested 
that Npn-2 is palmitoylated and that this lipid modification is required for Npn-2 
insertion into specific membrane domains along the cell surface. This prompted us to 
look more closely at the amino acid sequence of neuropilins and investigate whether 
neuropilins are indeed palmitoylated. 
 
Npn-1 and Npn-2 are S-palmitoylated in vitro and in vivo 
	
Both neuropilins, Npn-2 and Npn-1, harbor conserved cysteine residues in their 
transmembrane, juxtamembane and cytoplasmic domains. Npn-2 has three 
transmembrane/membrane-proximal cysteine residues (C878, C885 and C887) and also a 
cytoplasmic cysteine residue (C897) and a pair of C-terminal cysteines (C922 and C923; 
a C-terminal cysteine is defined here as being four positions from the stop codon), 
whereas Npn-1 has only three transmembrane/membrane-proximal cysteine residues 
(C875, C881 and C883) and no others (Figure 4, panel A). The numeration of the 
cysteine residues is done according to the position of these cysteines in the amino acid 
sequence of the Mus musculus Npn-2 isoform 002 (PubMed: ENSMUST00000063594) 
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for Npn-2, and the amino acid sequence of Mus musculus Npn-1 (PubMed: 
ENSMUST00000026917) for Npn-1.  
     Cysteines that lie in the membrane-proximal (or juxtamembrane) and cytoplasmic 
domains of transmembrane receptors are candidate palmitate acceptor sites. The position 
and the conservation of cysteine residues in the neuropilin coding sequence prompted us 
to investigate whether neuropilins are S-palmitoylated. To test this hypothesis, we 
utilized the Acyl-Biotin Exchange (ABE) method, a widely used biochemical assay that 
detects S-palmitoylation (Drisdel and Green, 2004; Drisdel et al., 2006; Kang et al., 2008; 
Wan et al., 2007), with which we assessed neuropilin palmitoylation in brain lysates, 
primary cortical neurons and cell lines. To perform the ABE method, free cysteine thiols 
are blocked with S-methyl methanethiosulfonate (MMTS) and then samples are 
incubated with hydroxylamine (HA, NH2OH), which cleaves thioester bonds, including 
those formed on thioesterified S-palmitoylated cysteines, or Tris buffer (-Hydroxylamine 
or –HA) as a control. The newly exposed cysteines (that were previously S-
palmitoylated) are biotinylated with a cysteine-specific biotin known as biotin-HPDP. 
Finally, the samples are incubated with streptavidin agarose resin to pull down the 
biotinylated proteins, which here represent the palmitoyl proteome. The detection of 
palmitoylated proteins is achieved by immunoblotting with an antibody directed against a 
protein of interest. If a protein is S-palmitoylated, there is a detectable signal in the +HA 
sample that is not present in the –HA sample and so -HA serves as an internal negative 
control.  
     We performed a large number of ABE experiments in different tissues, including cell 
lines (293T, N2A), deep layer cortical neurons derived from E14.5 WT embryos, and 
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brain lysates from various developmental time points (E14.5 cortical lysate, P21 
forebrain, P28 forebrain and adult mouse brain). These experiments revealed that both 
Npn-1 and Npn-2 are S-palmitoylated in primary cortical neurons and in the mouse brain 
(Figure 4, panels B and C). Notably, neuropilin palmitoylation is already strong at 
early embryonic stages (E14.5) and invariably persists in adulthood, suggesting that 
neuropilin palmitoylation is required throughout an animal’s life to regulate critical 
aspects of protein trafficking and function. In these assays, we also blotted against PSD-
95, a known palmitoyl substrate, and SAP-102, which is not (Kang et al., 2008).  
     The existence of a pair of C-terminal cysteines in the Npn-2 coding sequence raises 
the possibility that Npn-2 is also prenylated. Two proteins that have the same C-terminal 
cysteine cluster as does Npn-2, RhoB and paralemmin, are prenylated on the C-terminal 
side of the two cysteines (fourth from the stop codon) and palmitoylated upstream of the 
two cysteine residues (fifth from the stop codon) (Adamson et al., 1992; Fukata and 
Fukata, 2010; Kutzleb et al., 1998). The possibility that Npn-2 is prenylated was not 
tested in this current study. However, this possibility is interesting to investigate because 
prenylated proteins are subjected to a proteolytic maturation cleavage of their last three 
amino acids, and the newly exposed prenylated cysteine is methylated on its carboxyl 
group (Zhang and Casey, 1996). Given that the last three amino acids of Npn-2 make up 
a putative PDZ-binding motif, prenylation could regulate the fraction of Npn-2 that is 





Npn-1 and Npn-2 are enriched in lipid rafts in the mouse brain 
	
Protein palmitoylation is known to direct palmitoylated proteins into specialized 
domains of the plasma membrane that have a distinct composition of lipids and are 
known as detergent-resistant membranes, or lipid rafts (Levental I. et al., 2010). Lipid 
rafts play important roles in synaptic transmission acting as signaling platforms (Allen et 
al., 2007). Because neuropilins are robustly modified by palmitate, we wanted to test for 
enrichment of neuropilins in these domains. To this end, I fractionated brain lysates and 
isolated lipid rafts using a sucrose gradient. Twelve fractions were collected during this 
experiment. Samples from all collected fractions were immunoblotted with Npn-1 and 
Npn-2–specific antibodies. This experiment revealed that both Npn-1 and Npn-2 are 
enriched in the lipid raft fraction. The lipid raft fraction was identified during the 
experiment as an opaque white layer and by immunoblotting as the flottillin-1–rich 
fraction (Figure 5). As stated earlier, palmitoylation drives proteins into lipid rafts and 
promotes clustering. However, though both Npn-2 and Npn-1 are palmitoylated and lipid 
raft-enriched, only Npn-2 appears clustered. Given these data, the most likely 
explanation is that Npn-2 is enriched in specialized plasma membrane domains different 
from lipid rafts by means of its distinct protein-protein interactions (including 
interactions with palmitoylation machinery), as compared to Npn-1. Furthermore, these 
results suggest that palmitoylation on Npn-1 residues is functionally distinct from 




A structure/distribution analysis to identify determinants of Npn-2 clustering 
	
To better understand how Npn-1 and Npn-2 are differentially distributed on the cell 
surface, we sought to discover structural differences between Npn-1 and Npn-2 that are 
likely determinants of this distinctive distribution, since they are both palmitoylated. 
Qiang Wang, a post-doctoral fellow in the Kolodkin laboratory, started by using a cell 
line to look at the surface distribution of Npn-1 and Npn-2 in COS7 cells, which have a 
large surface area and allow for robust visualization of precise protein distribution. 
COS7 cells were transfected with N-terminally flag-tagged Npn-1– and Npn-2–
expressing plasmids. Following the expression of these Npns, live staining was 
performed with a flag antibody to visualize cell surface neuropilin protein. Npn-1 
exhibits a diffuse distribution over all membranes, whereas Npn-2 is highly clustered in 
the form of numerous discrete puncta (Figure 6). It has been shown that soluble proteins 
carrying one lipid group tend to be diffusely distributed, whereas proteins harboring 
additional lipid modifications are kinetically trapped and segregated in specific 
membrane domains (Rocks et al., 2010; Shahinian and Silvius, 1995). Diffuse 
distribution therefore seems to be a default distribution pattern, which is modified by the 
occurrence of additional molecular modifications. Provided that this is a prominent and 
invariable difference between Npn-1 and Npn-2, we sought to identify the structural 
domains of each neuropilin that dictate these patterns and account for this difference. 
Qiang Wang, in collaboration with our laboratory research technician Sarah Mitchell, 
generated a number of Npn-1/Npn-2 chimeric proteins, including receptors that have 
both their cytoplasmic and transmembrane domains swapped, or just their 
transmembrane domains (Figure 6, panel A). Hereafter, the mutant plasmids will be 
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referred to as Npn-a/b/c, with “a” denoting the ectodomain, “b” denoting the 
transmembrane domain with a few membrane-proximal amino acids and “c” denoting 
the cytoplasmic domain. Surprisingly, the Npn-2/1/1 and Npn-2/1/2 mutant proteins 
exhibit diffuse distribution, showing that the Npn-2 transmembrane domain along with a 
few membrane-proximal cytoplasmic amino acids is the principal determinant of the 
Npn-2 clustered distribution. Correspondingly, the mutants Npn-1/2/2 and Npn-1/2/1 
are, for the most part, clustered, showing that the Npn-1 transmembrane/membrane-
proximal domain regulates Npn-1 diffusion in the plasma membrane (Figure 6).  
     We then focused on the amino acid sequence of the neuropilin transmembrane 
domains and noted a few differences between Npn-1 and Npn-2. We assumed that some 
of these amino acids distinguish Npn-2 from Npn-1 with respect to their cell surface 
distribution. Qiang Wang and Sarah Mitchell generated and assessed a number of Npn-1 
and Npn-2 “swap” plasmids carrying complementary small motif changes. However, 
none of these smaller- Npn-1 and Npn-2-motif swap receptors showed a marked shift 
from the original distribution pattern of the parental WT protein (data not shown).  
     Taken together, these data show that single amino acids or very small sequences 
consisting of a few amino acids, do not dictate Npn-2 clustering.  However, they do 
show that the entire transmembrane/juxtamembrane region of 28 amino acids of Npn-2 
is likely required for Npn-2 clustering. This finding, in combination with a requirement 
for Npn-2 palmitoylation for clustering, suggests there exists special palmitoylation 
events occurring on the Npn-2 transmembrane/juxtamembrne domain cysteines 
(membrane-proximal cysteines) that lead to specific protein-protein interactions, and that 
those in turn drive Npn-2 clustering.    
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Palmitoylation on select Npn-2 cysteines is required for cell surface Npn-2 clustering 
in vitro 
	
Palmitoylation conveys certain neuronal proteins with the ability to become tethered to 
specific sites on the plasma membrane, and as a result they appear clustered (a punctate 
distribution). Thus far, we have shown that treatment of COS-7 cells expressing WT 
Npn-2 with 2-bromopalmitate abolishes the punctate distribution of Npn-2. This raises 
the question as to which Npn-2 cysteines are required for Npn-2 clustering via their 
palmitoylation. To address this issue, we assessed the surface distribution of various Npn-
2 mutant proteins in COS7 cells (in collaboration with Sarah Mitchell). COS7 cells were 
transfected with WT, C878S/C8885S/C887S (juxtamembrane cysteins; Figure 4, panel 
A), C922S/C923S (C-terminal cysteines) or full CS (all TM and cytoplasmic domain 
cysteines missing) Npn-2 proteins. Following one or two days of expression, cells were 
processed for live staining with an antibody directed against the extracellular (amino-
terminal) epitope tag of Npn-2. Several different experiments were performed with either 
pHluorin-tagged Npn-2 or flag-tagged Npn-2 expression plasmids. Experiments with 
both Flag-tagged and pHluorin-tagged Npn-2 proteins revealed that the WT and the 
C922S/C923S mutant Npn-2 both exhibit robust clustering on the cell surface. In marked 
contrast, the C878S/C885S/C887S Npn-2, or the full CS Npn-2, mutants lost their 
clustering and were distributed in a diffuse and non-selective manner over the entire cell 
surface membrane (Figure 7), reminiscent of the Npn-1 distribution. This finding, along 
with the loss of clustering following treatment with the palmitoylation inhibitor 2-
bromopalmitate (Figure 3), suggest that palmitoylation of Npn-2 on cysteines C878, 
C885 and C887 provides Npn-2 with the ability to cluster on the cell surface.   
	 26 
Neuropilin-1 and neuropilin-2 exhibit overlapping, but distinct, palmitoylation 
patterns 
	
We then sought to identify palmitoylated cysteine residues in the Npn-2 and Npn-1 
coding sequences. We generated various cysteine-to-serine (CS) point mutants in flag-
tagged Npn-2 (C878S, C885S, C887S, C878S/C885S/C887S (TCS mutant), C897S, 
C922S/C923S (C-terminal CS mutant), C878S/C885S/C887S/ C897S/ C922S/ C923S 
(full CS mutant)) and flag-tagged Npn-1 (C875S, C881S, C883S, C875S/C881S/C883S 
(full CS mutant)). For Npn-2, we also generated pHluorin-tagged Npn-2 CS point 
mutants (described later in this Chapter). We transfected neuroblastoma (N2A) cells with 
these plasmids and performed ABE to assess their palmitoylation levels as compared to 
the WT Npn-2 protein. This analysis showed that Npn-2 has a broad palmitoylation 
pattern and can be palmitoylated on almost all cysteine residues located in the 
transmembrane/ juxtamembrane and cytoplasmic domains, although to a variable extent. 
Specifically, C878 and C887 are robustly palmitoylated, C897 and the C-terminal 
cysteines are palmitoylated to a lesser extent, and C885 exhibits very little palmitoylation 
in this assay (Figure 8, panels A and B). The analysis of pHluorin-tagged Npn-2 showed 
similar results with flag-tagged Npn-2 (data not shown). On the other hand, Npn-1 is 
palmitoylated on C875 and C883, but not on C881, as shown by the reduced Npn-1 
palmitoylation levels in the absence of C875 or C883 compared to the WT protein 
(Figure 8, panels C and D).  
     Taken together, Npn-1 and Npn-2 exhibit distinct but overlapping palmitoylation 
patterns, however, in their transmembrane/membrane-proximal domains they are 
palmitoylated in a similar pattern. This in vitro palmitoylation analysis allowed us to 
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implicate certain cysteine residues as being major contributors to neuropilin 
palmitoylation. However, the identification of the specific cysteines that are 
palmitoylated in vivo requires the performance of mass-spectrometry. This experiment 
has technical challenges and requires expertise that precludes its prosecution at the 
present time. 
 
Select Npn-2 cysteines are required for Npn-2 association with the Golgi apparatus 
in cortical neurons  
	
The molecular and cellular mechanisms that mediate Npn-2 trafficking and distribution, 
and that could also explain the cell surface localization defects of certain Npn-2 cysteine 
point mutants, are largely unknown. Neuropilins are transmembrane receptors and so 
their passage through the secretory pathway, including the Golgi apparatus, must be an 
essential step in their posttranslational anterograde trafficking in order to be inserted into 
the plasma membrane and function as transmembrane receptors. Moreover, a potential 
association of a protein with the Golgi apparatus is interesting for three reasons that apply 
to our study: 1) the Golgi is the main subcellular compartment where palmitoylation 
occurs (Rocks et al., 2010); 2) the Golgi provides for polarized anterograde trafficking of 
secretory cargo and therefore it profoundly impacts the establishment of neuronal polarity 
(Horton et al., 2005); and 3) a potential Golgi-associated protein pool could dynamically 
respond to external stimuli such as Sema3F and also neural activity, therefore regulating 
the amount of the protein shuttled between the endomembrane system and the cell 
surface.  
     To ask whether or not neuropilins are associated with the Golgi apparatus, we 
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performed Golgi isolation from WT CD1 mouse brain lysates (see "Experimental 
Procedures"). This experiment showed that both Npn-1 and Npn-2 are enriched in the 
GM130-positive cis-Golgi fraction, as revealed by immunoblotting with protein-specific 
antibodies (Figure 9, panel A). To provide further evidence for neuropilin-Golgi 
association, we stained primary cortical neurons with antibodies directed against 
endogenous Npn-1 (goat), Npn-2 (goat) and GM130 (rabbit). This showed that 
endogenous neuropilins are associated with the somatic Golgi (a stack of interconnected 
cisternae localized in the perinuclear area) and also with Golgi outposts (longitudinal 
GM130-positive cisternae distributed along the main dendritic shafts) (Figure 9, panels 
B and C) detected in a subset of dendritic processes (consistent with (Horton et al., 
2005)). The enrichment of neuropilins in the Golgi apparatus suggests that bulk 
palmitoylation of neuropilins occurs on Golgi membranes, which is true for most known 
palmitoylated proteins (Rocks et al., 2010).  
     Because the palmitoylation status of a protein has been associated with its Golgi 
localization (Hayashi et al., 2005; Huang et al., 2004; Rocks et al., 2010), we 
hypothesized that Npn-2 cysteines are required for Npn-2−Golgi association. To test this 
hypothesis, we cultured E14.5 Npn2-/- primary cortical neurons and transfected them with 
either WT or the indicated cysteine-to-serine (C→S) point mutants of pHluorin-tagged 
Npn-2 (C878S/C885S/C887S, C922S/C923S, and full CS). Several days after 
transfection, neurons were subjected to triple immunofluorescence with a GFP antibody 
(chicken) to visualize Npn-2, GM130 (rabbit) to detect the cis-Golgi and the 
somatodendritic marker MAP2 (mouse). Single images were acquired with using 
confocal microscopy and were subjected to analysis with Image J. A detailed description 
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of this Npn2-Golgi association analysis can be found in the "Experimental Procedures" 
section of this Chapter. Briefly, channels were split, images were thresholded and the 
area of the GM130 (AGolgi), Npn-2 (ANpn2) or the colocalization area (ANpn2-Golgi) were 
measured. These data are expressed as a fraction of Golgi associated with Npn-2 (ANpn2-
Golgi/AGolgi).  
     WT Npn-2 associates with the cis-Golgi to a great extent. This is consistent with the 
enrichment of endogenous Npn-2 in the Golgi apparatus. This shows that the basic Npn-2 
trafficking properties are maintained by the exogenously expressed Npn-2, and that 
ectopic Npn-2 expression can be used to study Npn-2 trafficking. Similar to WT Npn-2, 
the C-terminal Npn-2 cysteine mutant C922S/C923S protein is associated with the 
somatic Golgi and Golgi outposts to a great extent, with no difference compared to the 
WT. On the contrary, the full CS Npn-2 exhibits a markedly reduced association with the 
cis-Golgi apparatus (Figure 9, panels D and E). Taken together, these findings point 
toward a role for the membrane-proximal cysteines in the Npn-2–Golgi association. The 
Npn-2 C878S/C885S/C887S mutant exhibits a reduced association with the Golgi marker 
GM130, but this defect is milder compared to the full CS. One plausible explanation for 
this observation is that the C897 also plays a role in Golgi localization, and/or when the 
three membrane-proximal cysteines are mutated (C878S/C885S/C887S) there is partial 
compensation mediated by C897. These findings suggest that the cysteine residues 
located in the membrane-proximal region are indispensable for proper Npn-2 localization 
on Golgi membranes. Given the reduced palmitoylation displayed by these mutants, and 
also the possible interaction between Npn-2 and select palmitoyl acyltransferases in the 
Golgi, it is likely that this defect results from the reduced palmitoylation of these Npn-2 
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mutant proteins.   
 
Effects of cysteines on Npn-2 distribution and trafficking in cortical neurons 
 
Given the punctate distribution of Npn-2 on the surface of COS7 cells and the 
requirement of the membrane-proximal Npn-2 cysteines for this clustering, we next 
wanted to assess the surface distribution of WT and CS Npn-2 in cortical neurons. To this 
aim, we cultured E14.5 WT primary cortical neurons on glass-bottom dishes and 
transfected them with pHluorin-tagged Npn2-IRES-dsRED expression plasmids. pHluorin 
is a pH-dependent variant of EGFP which fluoresces only at a basic pH; it therefore 
serves as a reporter of proteins expressed on the cell surface and exposed to the 
extracellular environment (Nl, 1998; Sankaranarayanan et al., 2000). Moreover, pHluorin 
is quite bright and suitable for a robust visualization of cell surface protein with live 
imaging. Neurons were imaged live using an inverted LSM700 microscope, and 
transfected neurons were identified by pHluorin and dsRed expression. Strikingly, Npn-2 
WT and the C878S/C885S/C887S Npn-2 mutant had a dramatically different distribution 
on the surface of cortical neurons, as assessed by the pHluorin signal. Specifically, WT 
Npn-2 is quite punctate, in accordance with its clustered pattern in cell lines; however, 
the C878S/C885S/C887S protein exhibits a very diffuse distribution along cortical 
neuron processes (Figure 10, panels C and D), with an almost complete loss of puncta. 
We also performed this experiment in Npn2-/- cortical neurons with the same results (data 
not shown). 
     The importance of the membrane-proximal Npn-2 cysteines for Npn-2 cell surface 
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clustering prompted us to investigate a potential role for these cysteines in Npn-2 
trafficking. To investigate this, we performed Fluorescence Recovery After 
Photobleaching (FRAP) experiments in collaboration with the Kolodkin laboratory post-
doctoral fellow Randal Hand. WT E14.5 cortical neurons (in a CD1 genetic background) 
were cultured on glass-bottom dishes that allow for live imaging. A few days later, 
neurons were transfected with either WT or C878S/C885S/C887S pHluorin-tagged 
Npn2−ires-dsRED expression plasmids and were incubated for several days after 
transfection in order to express the exogenous proteins at adequate levels. After their 
incubation for a total of at least 10 days in vitro, that allowed them to develop elaborate 
dendritic processes, neurons were subjected to FRAP analysis. For a detailed description 
of the experiment see the "FRAP" section in the Experimental Procedures below. 
Neurons included in this analysis had strong Npn-2 expression, based on the pHluorin 
signal, and a healthy morphology with elaborate dendritic processes. A Region Of 
Interest (ROI) was selected for subsequent bleaching. Time-lapse imaging was performed 
by the acquisition of an image every 30 seconds. Five images were acquired before 
bleaching (prebleach total time: 2.5 min.), one image right after bleaching (bleach), and 
30 images after bleaching (postbleach total time: 15 min.) in order to monitor 
fluorescence recovery over time. The laser-induced bleaching was very efficient, causing 
a reduction in fluorescence of at least 50% of the starting fluorescence levels in the ROI 
(a greater decrease was observed in most cases). Time-lapse image sequences were 
analyzed by measuring fluorescence in the ROI and correcting for the fluorescence decay 
that occured in a non-bleached area of the same neuron and also for background 
fluorescence. Representative images for each plasmid are shown, and pooled data are 
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presented for each plasmid as relative (normalized) fluorescence over time. Interestingly, 
WT Npn-2 exhibits a significantly lower fluorescence recovery as compared to the 
mutant C878S/C885S/C887S protein (Figure 10, panels A and B). This shows that WT 
Npn-2, most likely due to its palmitoylation, displays very tight membrane tethering and 
slow trafficking across the plasma membrane. This could result from its being trapped in 
specialized membrane domains, which is manifested as clustering and punctate 
distribution on the surface of cortical neurons. In marked contrast, the 
C878S/C885S/C887S mutant Npn-2 protein recovers to a much greater extent, suggesting 
that this protein exhibits less tight association with the plasma membrane, which is also 
reflected in its cell surface distribution characterized by a diffuse pattern.  
     Our observations are consistent with the kinetic characteristics of other palmitoylated 
proteins; specifically, the CS mutants of known palmitoylated proteins exhibit a stronger 
FRAP recovery compared to the WT protein (Rocks, 2005; Rocks et al., 2010). 
Therefore, work from others combined with our experimental results demonstrates that 
tight and spatially restricted protein trafficking is a general property of palmitoylated 
proteins, regardless of whether they are transmembrane or cytoplasmic. Furthermore, this 
property apparently results from protein palmitoylation, a modification that conveys to 
proteins specificity in trafficking not provided by the sole presence of a transmembrane 
domain.    	
Select Npn-2 cysteines are required for Sema3F/Npn-2−mediated dendritic spine 
constraint in cortical neurons 
	
Sema3F binds Npn-2 and constrains dendritic spine density along the main dendritic shaft 
in primary cortical pyramidal neurons in culture, and also on the apical dendrites of layer 
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V pyramidal neurons of the cerebral cortex in vivo in the postnatal and adult mouse brain 
(Tran et al., 2009). More specifically, Sema3F and Npn-2 null mice exhibit significantly 
higher dendritic spine density compared to their WT littermates. Furthermore, bath 
application of Sema3F on WT cortical neurons in culture constrains spine density, as 
compared to control treatment. These loss-of-function and gain-of-function experiments 
demonstrate that Sema3F/Npn-2 signaling acts to regulate the density of dendritic spines 
in deep layer cortical pyramidal neurons and, subsequently, the number of excitatory 
synapses formed onto these neurons. Here, we provide experimental evidence that the 
membrane-proximal Npn-2 cysteines, but not the C-terminal cysteine residues, are 
required for Npn-2 to serve as a negative regulator of dendritic spines in cortical neurons.  
     As I have already shown, the membrane-proximal Npn-2 cysteines C878, C885 and 
C887 play critical roles in Npn-2 trafficking and distribution, most likely via their 
palmitoylation (Figures 3 and 7). To test whether the various transmembrane and 
cytoplasmic Npn-2 cyseine residues are important for Sema3F/Npn-2–mediated spine 
constraint in cortical neurons, we performed rescue experiments in Npn-2-/- primary 
cortical neurons treated with alkaline phosphatase conjugated Sema3F (Sema3F-AP) or 
AP control. We cultured E14.5 Npn-2-/- cortical neurons for a total of 21 days-in-vitro 
(DIV) so that the neurons were fully developed and had mature spines. At DIV8, neurons 
were transfected (using Lipofectamine) with various pCIG2-IRES-EGFP expression 
plasmids, including a flag-tagged WT Npn-2 and also flag-tagged Npn-2 cysteine-to-
serine (CS) point mutants. At DIV21, neurons were treated with 5nM Sema3F-AP or AP 
for 6 hours. Following this treatment, neurons were fixed and processed for 
immunofluorescence, which included a GFP antibody (chicken) to visualize neuronal 
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morphology with high resolution and a Npn-2 antibody (rabbit) to detect and confirm 
Npn-2 protein expression from the various plasmids. Neurons were imaged with the 
acquisition of stacks using a 63X oil lens (upright LSM700) and the 3D projection of 
each stack was generated (Image J). These 3D projections of cortical neurons in culture 
were used for dendritic spine analysis. All dendritic spines (mushroom, stubby, filopodia-
like spines) were counted along the proximal 50 µm of the main dendritic shaft emerging 
from the pyramidal neuron cell body. Representative images of neurons expressing each 
of the tested plasmids are shown, and pooled data are quantified and presented as a 
number of spines per µm, following either Sema3F-AP or AP treatment (Figure 11).  
     Neurons transfected with EGFP only (with no Npn-2 expression) did not respond to 
Sema3F (no significant difference between Sema3F-AP and AP treatment) and also had 
significantly more spines as compared to the neurons expressing WT Npn-2 and treated 
with Sema3F-AP. This shows that WT Npn-2 rescues the Npn-2–associated dendritic 
spine phenotype, as observed previously (Tran et al, 2019). Importantly, there is also a 
significant difference between EGFP only-expressing neurons and neurons expressing 
WT Npn-2, both treated with AP; this suggests that in the absence of exogenous Sema3F, 
Npn-2 WT partially rescues the dendritic spine phenotype. This raises the possibility that 
Sema3F itself is expressed in these deep layer primary cortical neuron cultures. In fact, 
we have confirmed that Sema3F is secreted by primary E14.5 cortical neuron cultures by 
immunoblotting concentrated culture medium derived from E14.5 primary cortical 
neurons harvested from a 6xMyc-tagged Sema3F knock-in mouse we generated 
(Sema3FMyc; see Chapter 4, Figure 26). This likely explains why WT Npn-2 is able to 
constrain spine density without the application of exogenous Sema3F ligand in our 
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cortical neuron cultures.    
     Npn2-/- cortical neurons expressing the Npn2 C-terminal cysteine mutant 
C922S/C923S also responded to Sema3F and had fewer spines compared to Npn2-/- 
neurons that expressed only EGFP; there was no significant difference from the WT 
Npn2-expressing neurons. Therefore, the C-terminal Npn-2 cysteines (C922, C923) are 
not required for spine constraint. On the other hand, neurons expressing the Npn-2 point 
mutants C878S or C887S had spines that were as numerous as the spines observed in the 
negative control (EGFP only). Furthermore, these neurons displayed no response to 
Sema3F, as compared to the AP control, and they were also significantly different from 
WT Npn-2 expressing neurons. These data demonstrate that cysteines C878 and C887 are 
indispensable for Npn-2 to serve as a negative regulator of dendritic spines through the 
action of Sema3F. Lastly, C885 and C897 residues play a less important, but significant, 
role in spine constraint, since they partially rescued the spine phenotype (showing a 
significant difference from neurons expressing only EGFP and also from neurons 
expressing WT Npn-2). Of note, we also performed immunofluorescence against Npn-2 
to confirm protein expression and rule out the possibility that some plasmids do not 
rescue because of differences in expression levels—we find that indeed all Npn-2 
constructs are expressed at comparable levels at the cell surface (qualitative assessment 
thus far − data not shown).  
     In summary, there is a requirement for select Npn-2 cysteine residues for the 
regulation of dendritic spine number by Sema3F/Npn-2 signaling in cortical neurons. 
These data (Figure 11), along with our data on the palmitoylation of various Npn-2 
cysteine point mutants (Figure 8, panels A and B), show a strong correlation between 
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the extent to which certain cyteines are palmitoylated and their contribution to the rescue 
of dendritic constraint following treatment with Sema3F. In greater detail, cysteines that 
are strongly palmitoylated (C878, C887) are necessary for rescuing the Sema3F-induced 
spine phenotype, whereas cysteines that are palmitoylated to a lesser extent have either 
intact (C922/C923) or partially compromised (C885, C897) rescue ability. This suggests 
a role for palmitoylation rather than the cysteine residues themselves in Npn-2 function. 
In subsequent chapters below we address this issue in more experimental detail. 
     Finally, it is intriguing the fact that the Npn-2 C922S/C923S mutant protein 
completely rescues the Npn2-/--associated spine constraint phenotype and raises the 
possibility that this cysteine motif has a different Npn-2–associated function. As I discuss 
below in the "Conclusions-Discussion" section of this chapter, preliminary experimental 
evidence suggests a different function for the Npn-2 C-terminal cysteines, which supports 
the notion that there is functional segregation within the Npn-2 
transmembrane/cytoplasmic domains that involves these cysteine residues. On the other 
hand, the C-terminal SEA motif that Npn-2 harbors, which lies C-terminal to the C-
terminal cysteines (CCSEA∗), has been shown to be essential for spine constraint in 
response to Sema3F (Tran et al., 2009). Our current model suggests that this motif is a 
PDZ-binding motif, and therefore, it might mediate interactions of Npn-2 with PDZ-
domain–containing proteins.  
 
Sema3F enhances Npn-2 palmitoylation in cortical neurons 
   
Palmitoylation is a reversible post-translational modification that dynamically modifies a 
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protein properties, and external stimuli such as glutamate may alter baseline protein 
palmitoylation (Hayashi et al., 2009; Kang et al., 2008). Thus, we speculated that steady-
state Npn-2 palmitoylation is altered in response to its physiologically relevant secreted 
ligand Sema3F. To investigate this, we treated WT CD1 E14.5 primary cortical neurons 
with 5nM Sema3F-AP, Sema3A-AP or AP control ligands for various periods of time 
including one hour-, two hour- and 6 hour-treatments and then performed ABE to assess 
endogenous Npn-2 palmitoylation. These experiments revealed that exogenous Sema3F 
robustly enhanced palmitoylation of endogenous Npn-2 in primary cortical neurons, 
whereas Sema3A-AP treatment left Npn-2 palmitoylation unaltered (Figure 12, panes A 
and B). This finding is important for two reasons: 1) it shows that Sema3F can be a 
regulator of Npn-2 palmitoylation and, more importantly, 2) it provides a link between 
Sema3F signaling and Npn-2 palmitoylation. A direct effect of Sema3F on the 
palmitoylation of specific Npn-2 cysteines could not be investigated because cell lines 
(neuroblastoma N2A cells) expressing exogenous Npn-2 did not show a similar effect: no 
response in cell lines was detected following several experiments (data not shown). The 
lack of response of Npn-2 palmitoylation to Sema3F in N2A cells might be due to the 
lack of the highly specialized machinery expressed in cortical neurons (synaptic partners, 
scaffolding and signaling proteins, palmitoyl acyltransferases).  
     The enhancement of Npn-2 palmitoylation by exogenously applied Sema3F suggests 
that baseline Npn-2 palmitoylation is regulated by external stimuli, and that Npn-2 
palmitoylation is required for Npn-2 response to Sema3F. Moreover, provided that Npn-2 
palmitoylation causes changes in Npn-2 distribution and trafficking, we could speculate 
that response to Sema3F requires a redistribution of Npn-2, mediated by the recruitment 
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of certain palmitoyltransferases that catalyze specific palmitoylation events on Npn-2.  
 
Neuronal activity alters Npn-2 palmitoylation 
	
Alterations in neural activity in vitro or in vivo modulate palmitoylation of numerous 
neuronal palmitoyl substrates (Hayashi et al., 2009; Kang et al., 2008). We therefore 
tested the hypothesis that activity alters steady-state Npn-2 palmitoylation, in 
collaboration with Qiang Wang. WT CD1 E14.5 primary cortical neurons grown for at 
least two weeks in vitro were treated with TTX or bicuculline for two hours, or for two 
days; following treatment, neurons were harvested and subjected to the ABE assay to 
assess palmitoylation of endogenous neuronal proteins. All treatments (TTX and 
bicuculline, two-hour and two-day) caused a dramatic reduction in Npn-2 palmitoylation. 
The same was observed for PSD-95 (Figure 12, panels D and E). These data suggest 
that proper activity levels and balanced neuronal activity is required for appropriate Npn-
2 palmitoylation. However, these data obtained here are partially inconsistent with 
previous work, which shows that a decrease in activity (induced by TTX) causes a 
compensatory upregulation of palmitoylation of NR2A and NR2B (Hayashi et al., 2009). 
This discrepancy could be explained by variability in the type of neurons cultured and/or 
the treatment conditions. However, regardless of the polarity of the palmitoylation 
response (increase or decrease), these findings show that activity significantly alters Npn-
2 palmitoylation, as has been shown for other neuronal proteins (Brigidi et al., 2014b; 
Hayashi et al., 2009; Kang et al., 2008). A rigorous assessment of activity-induced Npn-2 
palmitoylation changes will require very carefully designed experiments with respect to 
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the neurons used (cortical versus hippocampal, CD1 versus other backgrounds, deep 
cortical layer (E14.5) versus upper cortical layer (E15.5)), days of in vitro incubation and 
the applied treatment. The latter should include a very short bath application of the 
compounds on neurons, including a 5-minute time point. Moreover, the above-described 
discrepancy could be due to reciprocal changes in excitatory and inhibitory synapses, 
which could be separated with biochemical fractionation.   
 
In vivo rescue of the Npn2-/-−associated dendritic spine phenotype 
  
The requirement for select Npn-2 cysteines in Sema3F-mediated spine collapse in vitro 
prompted us to investigate whether these residues are also required for Npn-2 spine 
constraint in the mouse cerebral cortex. To this aim, we performed rescue experiments of 
the Npn2-/--associated increased dendritic spine phenotype in Npn-2-/- deep layer cortical 
neurons using an in utero electroporation protocol in collaboration with both Qiang Wang 
and Randal Hand. To circumvent the lethality and low breeding efficiency associated 
with the Npn2-/- mouse line, I crossed Npn2-/- with Npn2F/F so that all embryos of the 
litter are Npn2F/-. In utero electroporation was performed at E13.5 in order to target deep 
layer cortical neurons with the goal to assess their spine density. This scheme for 
electroporations (Figure 13, panel A) includes two controls: 1) pCIG2-ires-EGFP to 
visualize neuronal morphology in Npn2F/- neurons; and 2) pCIG2-ires-EGFP + pCAG-
Cre + LSL-tdTomato to excise the floxed Npn-2 allele and render deep layer neurons 
Npn2-/-. LSL-tdTomato (LoxP-STOP-LoxP-tdTomato) is co-electroporated to serve as a 
reporter of Cre activity. If this strategy works, neurons with excision of the floxed Npn2 
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allele (control 2) should have more spines compared to the neurons expressing only 
EGFP (control 1), recapitulating the Npn2-/- spine phenotype. Importantly, this analysis 
revealed that, indeed, neurons expressing both Cre and EGFP (and thus Npn2-/-) have a 
higher spine density compared to neurons expressing only EGFP (Figure 13, panels B 
and C).  
     Next, we electroporated another litter with Flag-Npn2 WT-ires-EGFP + Cre + LSL-
tdTomato, in order to assess whether WT Npn-2 rescues the Npn2-/- spine phenotype. 
Deep layer Npn2-/- cortical neurons expressing WT Npn-2 had a spine density similar to 
that of Npn2F/- neurons expressing EGFP alone, showing that WT Npn-2 completely 
rescues the spine phenotype associated with Npn2 deletion (Figure 13). To test the 
importance of the Npn-2 membrane-proximal cysteines, we assessed the rescue ability of 
the Npn-2 C878S/C885S/C887S mutant by electroporating embryos with flag-Npn2 
C878S/C885S/C887S-ires-EGFP + Cre + LSL-tdTomato. Importantly, this mutant was 
not capable of rescuing the increased dendritic spine density phenotype. Taken together, 
these results reveal a requirement for the membrane-proximal Npn-2 cysteines in 
Sema3F-induced dendritic spine constraint in deep layer cortical neurons.   
 
Npn-2 cysteines are not required for Npn-2/plexin-A3 interaction or Npn-2 
homodimerization in vitro 
	
The interaction between Npn-2/plexinA3 is critical for constraining spine density in 
response to Sema3F (Tran et al., 2009). We therefore wanted to know whether Npn-2 
cysteines are required for Npn-2 interactions with plexinA3. To address this, we co-
transfected 293T cells with myc-tagged plexinA3 and either WT or full CS Npn-2 and 
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then performed co-immunoprecipitation experiments. These biochemical assays revealed 
that full CS Npn-2 associates with plexinA3 as efficiently as does WT Npn-2 (Figure 14, 
panel A). This finding shows that the abolished rescue ability of the Npn-2 CS is not due 
to a lack of Npn-2 binding to plexinA3.  
     It is known that Npn-2 forms homodimers (Chen et al., 1998). Because cysteines can 
form disulfide bridges with adjacent cysteines, it is possible that Npn-2 cysteines mediate 
Npn-2 homodimerization via the formation of intermolecular disulfide bonds. To test 
whether membrane-proximal and/or cytoplasmic Npn-2 cysteines are required for Npn-2 
homodimerization, we performed co-immunoprecipitation experiments involving Flag–
Npn-2 and either WT or full CS pHluorin–Npn-2. This experiment showed a very strong 
association of full CS pHluorin-Npn-2 with WT Flag-Npn-2, similar to the association of 
WT pHluorin-Npn-2 with WT flag-Npn-2 (Figure 14, panel B). This finding suggests 
that these cysteine residues do not form disulfide bridges critical for intermolecular 




My work identifies two guidance cue receptors broadly implicated in neural 
development, Npn-1 and Npn-2, as novel palmitoylated neuronal proteins. Npn-2 
palmitoylation on transmembrane/membrane-proximal cysteines is essential for Npn-2 
distribution, trafficking, and also most likely Sema3F/Npn-2–mediated spine constraint, 
whereas the Npn-2 C-terminal cysteines are apparently not required for either spine 
constraint or Npn-2 clustering.  
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     Npn-1 and Npn-2 undergo trafficking through the Golgi apparatus. Npn-2 membrane-
proximal cysteines are required for its stabilization and enrichment in Golgi membranes. 
This apparently renders the protein available to effectors of post-Golgi anterograde 
trafficking pathways that ensure its distribution into specialized plasma membrane 
domains, as revealed by the loss of clustering and segregation in cell surface subdomains 
following mutations in Npn-2 membrane-proximal cysteines. It is therefore likely that the 
defective cell surface Npn-2 C878S/C885S/C887S distribution results, at least in part, 
from aberrant Npn-2 Golgi localization. Importantly, the interesting correlation among 
the rescue ability of the various Npn-2 cysteine mutants, the cell surface distribution if 
these Npn-2 cysteine mutants in COS7 cells and cortical neurons, and the association 
patterns of these Npn-2 cysteine mutants with the Golgi apparatus in cortical neurons 
may very well provide a plausible explanation for the rescue ability of the C-terminal 
Npn2 (C922S/C923S) mutant and also the inability of the transmembrane and membrane-
proximal CS Npn-2 (C878S/C885S/C887S) mutant to rescue the Npn2-/-−associated spine 
density phenotype. We speculate that the C878S/C885S/C887S Npn-2 mutant cannot 
respond to Sema3F (although it is able to bind Sema3F) with spine constraint because it 
is not properly localized. On the other hand, the C-terminal C922S/C923S Npn-2 mutant 
rescues the Npn2-/--associated dendritic spine phenotype because it still is able to assume 
proper localization at the neuron cell membrane.  
     The role of palmitoylation in Npn-2 protein clustering suggested by our work 
presented thus far is consistent with previous studies showing that palmitoylation-
deficient mutant proteins lose their clustering and become diffusely localized in the cell 
membrane (Noritake et al., 2009). However, Npn-1 and Npn-2 share the same 
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organization of cysteine residues in their transmembrane and membrane-proximal 
domains, yet they have completely different cell surface distribution patterns. We 
therefore speculated that these cysteines are necessary, but not sufficient, for Npn-2 
clustering and then tried to identify additional Npn-2 sequences that might be required. 
We found that, for the most part, the Npn-2 transmembrane and juxtamembrane domains 
dictate Npn-2 clustering, however the smaller Npn-1/Npn-2 chimeras we generated and 
assessed for clustering did not reveal a requirement for a specific amino acid sequences 
adjacent the Npn-2 cysteines. We therefore have to consider the entire Npn-2 
transmembrane/membrane-proximal domain of 28 amino acids as a determinant of Npn-2 
cell surface clustered localization. This finding, in combination with the abolition of Npn-
2 clustering observed when the three membrane-proximal cysteines are mutated to serine 
or upon 2-bromopalmitate treatment, show that palmitoylation of Npn-2 on membrane-
proximal cysteines has features that must be distinct from the palmitoylation of Npn-1 
membrane-proximal cysteines. Such a functional divergence could result from distinct 
interactions between Npn-1 and Npn-2 and with different palmitoyl acyltransferases, 
resulting in subsequent differences in palmitoylation of these two receptors. This issue is 
addressed below in Chapter 3.  
     Further, we have not yet determined the identity of the cell surface domains or 
compartments in which the Npn-2 clusters localize. It is well documented that 
palmitoylation targets proteins for insertion into lipid rafts (more precisely known as 
“detergent-resistant domains”) (Levental et al., 2010). However, we have found that both 
Npn-1 and Npn-2 are enriched in the lipid raft fraction isolated from mouse brain lysates 
(Figure 5), as expected since they are both palmitoylated. This is consistent with 
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evidence that Sema3A-mediated axon guidance is dependent on the integrity of lipid rafts 
(Guirland et al., 2004). Therefore, the lipid raft hypothesis cannot on its own explain the 
differential cell surface distribution between Npn-1 and Npn-2.  
     The Npn-2 C-terminal cysteines C922 and C923 are dispensable for Npn-2 spine 
constraint. It is therefore likely that these residues play critical roles in other aspects of 
Npn-2 function, perhaps infrapyramidal tract pruning (Riccomagno MM. et al., 2012) or 
proper development of Npn-2–dependent axonal tracts (i.e. the anterior commissure). 
According to unpublished data generated in the Kolodkin laboratory by former 
postdoctoral fellow Martín Riccomagno (personal communication), the Rac GTPase 
activating protein (GAP) signaling protein β2-chimaerin interacts more robustly with the 
C922S/C923S Npn-2 mutant protein than with the WT Npn-2 protein, whereas mutation 
of the membrane-proximal Npn-2 cysteines leaves this interaction unaltered. However, 
β2-chimaerin exerts its effect on axon pruning upon its dissociation from Npn-2 
(Riccomagno et al., 2012). So, the C-terminal cysteines might serve to downregulate β2-
chimaerin /Npn-2 interactions so that β2-chimaerin can mediate pruning of the 
infrapyramidal tract. If this were true, the C922S/C923S Npn-2 mutant protein would 
prevent β2-chimaerin from exerting its pruning effect. This interplay might result from 
prenylation of the Npn-2 C-terminal cysteine, which would lead to proteolytic cleavage 
and carboxy-methylation of the Npn-2 C-terminus and could, therefore, regulate this 





Analysis of palmitoylation 
Acyl-Biotinyl Exchange (ABE) assay: performed according to (Wan et al., 2007), with 
slight modifications according to Hayashi et al. (2009). Briefly, on day 1, tissue is lysed 
in lysis buffer containing Methyl MethaneThioSulfonate (MMTS, Sigma, cat. no. 64306), 
which blocks free thiols. On day 2, inputs are taken from each sample and then samples 
are incubated with either a buffer containing Hydroxylamine (+HA buffer/sample) 
(Thermo Scientific, cat. no. 26103), which cleaves thioester-linked acyl modifications, or 
with a control buffer containing Tris (-HA buffer/sample). HPDP-biotin (Soltec Ventures, 
cat. no. B106) is used as a cysteine-specific biotinylation agent to biotinylate newly 
exposed cysteine thiols and is included in both +HA and -HA buffers. On day 3, all 
samples are incubated with low HPDP-Biotin buffer. On day 4, samples are incubated 
with Streptavidin agarose resin (Thermo Scientific, cat. no. 20349) in order to affinity 
purify biotinylated proteins, which represent the palmitoyl proteome. Finally, on day 5, 
resin is washed twice with no salt and twice with high salt (500mM NaCl) buffers and 
protein is dissociated from the resin by incubation with a 2-mercaptoethanol–containing 
buffer at 37ºC for 10 minutes with flick mixing. Supernatants are then transferred to clean 
Eppendorf tubes. Inputs and processed (+HA, -HA) samples are analyzed by SDS-
polyacrylamide gel electrophoresis and immunoblotting with protein-specific antibodies.  
 
Biochemical assays  
SDS-PAGE and immunoblotting (Western blotting): samples were mixed with 4x 
Laemmli buffer to a final concentration 1x (4x Laemmli: 10% 2-mercaptoethanol (Sigma, 
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cat. no. M6250), 90% 4x Laemmli sample buffer (Bio-rad, cat. no. 161-0747)), boiled for 
5 minutes and stored at -20°C. Samples were run on 4-20% Mini-Protean TGX Precast 
gels (Bio-Rad, 10-well comb, cat. no. 456-1093; 15-well comb, cat. no. 456-1096), run 
under standard protein electrophoresis conditions and transferred on PVDF transfer 
membrane (Immobilon-P, Millipore, cat. no. IPVH00010). Membranes were blocked 
with 5% milk (Scientific, cat. no. M0841) diluted in TBS-T, for 1 hour at room 
temperature. Incubation with primary antibodies was performed in 5% milk at 4°C 
overnight, with rotation. The next day, membranes were washed 3x, 10 minutes each, 
with TBS-T. Secondary HRP-conjugated species-specific antibodies were diluted in 1% 
milk to a final concentration 1:10.000, and incubated with membranes for 1 hour at room 
temperature, with gentle shaking. Membranes were washed 4x, 10 minutes each, with 
TBS-T. The signal detection was performed with ECL (GE Healthcare) or ECL Prime 
(GE Healthcare) or Clarity (Biorad).  
Primary antibodies: Neuropilin-2, 1:1000, rabbit, Cell Signaling cat. no. 3366S; 
Neuropilin-1, 1:1000, rabbit, AbCam cat. no. ab81321; Neuropilin-1, 1:1000, goat, R & 
D cat. no. AF566; PSD-95, 1:1000, mouse, NeuroMab, cat. no. 75-028; GM130, 1:1000, 
rabbit, AbCam; flotillin-1; actin; SAP102, NeuroMab, cat. no. 75-058.   
Secondary antibodies: HRP-conjugated species-specific antibodies. 
 
Co-immunoprecipitation: tissue was lysed in TNE buffer (NP-40, Tris, EDTA, NaCl, 
protease inhibitors). Samples were precleared with resin for 2 hours. After the preclear 
step, resin was discarded and supernatants were transferred to clean Eppendorf tubes. A 
small amount was kept and labeled as input and the rest of the samples were incubated 
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with antibody overnight at 4oC. Next day, protein A/G agarose resin (Thermo Scientific) 
was added to the samples and samples with resin were incubated at 4oC, for 2 hours, with 
end-over-end rotation. Resin was washed twice with high-salt buffer (500mM NaCl) and 
twice with low-salt buffer (150mM NaCl). Samples were mixed with Laemmli buffer, 
boiled and subjected to SDS-PAGE and immunoblotting.   
 
Lipid raft isolation: detergent-resistant membranes (DRMs) or lipid rafts were isolated 
according to the "Isolation and Use of Rafts" protocol provided in the Current Protocols 
in Immunology textbook (Unit 11.10). In detail, wholebrains from WT CD1 mice were 
homogenized in TNE buffer (25mM Tris pH=7.4, 150 mM NaCl, 5mM EDTA, 1X 
Protease inhibitor cocktail, 1% Triton X-100) and debris was pelleted with centrifugation 
at 13.000 rpm. 2 ml supernatant (lysate) were mixed with 2 ml 80% sucrose and this 40% 
sucrose/lysate mix was placed at the bottom (bottom layer) of a Beckman ultracentrifuge 
tube (cat. no. 344059). This was overlayed with 4 ml 30% sucrose and this in turn was 
overlayed with 4 ml 5% sucrose. Ultracentrifugation was performed at 118,000g (26.200 
rpm) with a SW41 rotor for 16 hours at 4ºC. The material centrifuged and distributed 
along the sucrose gradient was harvested by the collection of 12 1-ml fractions. The 
opaque layer representing DRMs was found at the 5%-30% sucrose interface (fraction 5: 
very solid white). Samples were mixed with Laemmli buffer and analyzed with SDS-
PAGE followed by immunoblotting with protein-specific antibodies.     
 
Golgi isolation: mouse whole brain was harvested and homogenized with a gentle pestle 
(Potter-Elvehjem homogenizer) to avoid Golgi stack fragmentation. Golgi stacks were 
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isolated by flotation through a discontinuous sucrose gradient according to the Basic 
Protocol 2 described in Unit 3.9 of the Current Protocols in Cell Biology. Briefly, light 
mitochondrial pellet was resuspended in 2 ml buffer and mixed with 8 ml 2.0 M sucrose 
so that final sucrose concentration is about 1.55 M. 5 ml of this mix was transferred to a 
17-ml ultracentrifuge tube (Beckman) and overlayed with the following sucrose 
solutions: 4 ml 1.33 M sucrose, 2 ml 1.2 M sucrose, 2 ml 1.1 M sucrose, 2 ml 0.77 M 
sucrose, 0.25 M sucrose to fill the tube. Gradients were ultracentrifuged at 100,000 x g at 
4˚C for one hour. Six fractions were collected in total: 1.55M, 1.55M/1.33M, 1.33M, 
1.1M/1.2M, intervening material, 0.77M/1.1M. Samples were mixed with Laemmli 
buffer, boiled and analyzed with SDS-PAGE and immunoblotting with Npn-2, Npn-1 and 
GM130 antibodies.  
 
2-bromopalmitate treatments 
2-bromohexadecanoic acid (also known as 2-bromopalmitate) (Sigma-Aldrich, cat. no. 
238422) was dissolved in Dimethyl Sulfoxide (DMSO, Sigma-Aldrich, cat. no. D2650) 
to make a stock. Stock solution was diluted in the appropriate culture medium to the 
indicated final concentrations (50µM or 10µM). Cells with 2-bromopalmitate–containing 
medium were incubated at 37oC, 5% CO2, for 6 hours or overnight. 
 
Primary cortical cultures 
Cortical cultures: timed-pregnant mice were either obtained from external mouse 
facilities (CD1 from Charles River; C57BL6 from Jackson Laboratories) or generated in-
house by plug checks. Embryos were harvested at E14.5 (for deep cortical layer cultures) 
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and cerebral hemispheres were dissected out. The olfactory bulbs and the ganglionic 
eminences were removed and discarded and the cortices were kept on ice-cold L-15 
medium (Leibovitz, Gibco). Tissue was trypsinized with 0.1% trypsin diluted in HBSS 
(Gibco) for 15 minutes in a 37oC-water bath. Following trypsinization, cortices were 
washed twice with HBSS+10% FBS to inactivate trypsin and dissociated in neuron 
growth medium containing 10% FBS. Neurons in neuron growth medium were plated in 
6-well plates for the performance of biochemical experiments or on 24-well plates 
containing round glass coverslips for immunofluorescence. Medium was partially 
changed every three days.  
 
Plate/coverslip preparation: 12 mm round glass coverslips were treated with nitric acid 
overnight, washed with ddH2O and ethanol and stored in 95% ethanol. The day of 
culture, coverslips were flamed, placed in 24-well plates and coated with 0.1mg/ml poly-
D-lysine diluted in ddH2O for at least two hours at 37ºC. Before plating of neurons, plates 
with coverslips were washed twice with DPBS. 
 
Immunofluorescence 
In vitro: cells were fixed with 4% PFA (prepared in 1x PBS from 16% EM-grade PFA 
(Electron Microscopy Sciences, cat. no. 15710)) for up to 10 minutes at room 
temperature, washed with PBS three times for 10 minutes each, and blocked with 10% 
goat or donkey serum and 0.1% Triton X-100 in PBS for one hour. Cells were incubated 
with primary antibodies overnight at 4ºC with gentle shaking. Next day, they were 
washed three times with PBS for 10 min each, and then incubated with secondary 
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antibodies for one hour at room temperature in the dark. Primary and secondary 
antibodies were diluted in 1% goat or donkey serum and 0.1% Triton X-100 in PBS. 
Following the incubation with secondary antibodies, cells were washed four times for 10 
min. each with PBS and glass coverslips were placed upside-down on glass slides with 
mounting medium (Electron Microscopy Sciences, Fluoro-gel, cat. no. 17985). Primary 
antibodies: GFP (chicken, Avés, cat. no. GFP-1020), Npn-2 (rabbit, Cell Signaling, cat. 
no. 3366S), Npn-2 (goat, R & D), Npn-1 (goat, R & D), GM130 (rabbit, AbCam), dsRed 
(rabbit, Living Colors), flag (mouse M2, Sigma). Secondary antibodies: 488 donkey 
anti-chicken IgY (Biotium, cat. no. 20166), Alexa Fluor 647 donkey anti-rabbit IgG (Life 
technologies), Alexa Fluor 555 donkey anti-rabbit IgG (Life Technologies), Alexa Fluor 
488 donkey anti-goat IgG (Life technologies), Alexa Fluor 555 goat anti-mouse IgG (Life 
Technologies), 647 donkey anti-rat IgG (Jackson).    
      
Live staining:  
Cells were incubated with primary antibody (Flag 1:50, GFP (chicken) 1:500) diluted in 
culture medium, for 10 min at room temperature. Then, they were washed three times 
with culture medium, and fixed with 4% PFA for ~10 min. Cells were washed with PBS, 
blocked and incubated with a fluorescent secondary antibody for one hour at room 
temperature. Finally, cells were washed and mounted.  
 
Npn-2–Golgi association analysis 
For the analysis of the Npn-2 and GM130 colocalization, I used Image J. The Npn-2 and 
Golgi (GM130) channels were split and thresholded (a different threshold was used for 
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each of the two channels), while thresholds were kept constant throughout the analysis. 
The area of the Npn-2 (ANpn2) and the Golgi (AGolgi) was selected and measured (µm2). 
The colocalization plugin was used to find the colocalized area (AGolgi-Npn2), which was 
then selected and measured. To assess the colocalization, the fraction of the Golgi 
associated with Npn-2 (AGolgi-Npn2/AGolgi) was calculated.   
 
Fluorescence Recovery After Photobleaching (FRAP) 
E14.5 WT CD1 primary cortical neurons were cultured as described above and plated on 
glass bottom dishes (MatTek, cat. no. P35G-0-14-C) precoated with poly-D-lysine. 
Between DIV 5 and DIV 8, neurons were transfected with the indicated pHluorin-Npn2-
ires-dsRED expression plasmids using Lipofectamine (Lipofectamine 2000 Reagent, 
Invitrogen, cat. no.11668-019). Several days after transfection, transfected neurons, 
identified by the robust expression of pHluorin-tagged Npn-2 and dsRED, were imaged 
with an inverted LSM 700 microscope (Zeiss) with an incubation chamber (PeCon) 
(temperature: 37ºC, CO2: 5%), using a 63X NA1.4 oil immersion lens. For the 
performance of fluorescence recovery after photobleaching (FRAP), we used the 
following protocol: a Region Of Interest (ROI) containing the main dendritic process was 
selected for FRAP analysis. Images were acquired every 30 seconds; 5 images were 
acquired prior to bleaching (prebleach time: 2.5 minutes) and 31 additional images were 
acquired post-bleaching (total post-bleach time: 15.5 minutes).  
Analysis: Fluorescence intensity of time-lapse images was determined by measuring the 
fluorescence intensity within the ROI and correcting for fluorescence decay and for 
background fluorescence. Pooled data are presented for each plasmid (pHluorin-Npn2 
	 52 




HEK293T cells were transfected with the appropriate expression plasmids with the 
method of Lipofectamine (Invitrogen, Lipofectamine 2000 Reagent), and they were 
allowed to express and secrete the ligand for 2-5 days. The resulting culture supernatant 
was centrifuged at a low speed at 4ºC for 5 min. and supernatant was transferred to a 
clean filter tube for concentration. For AP concentration, a filter of 50K was used, 
whereas for Sema3A-AP or Sema3F-AP a filter of 100K was used (Millipore). The 
concentration of the ligands was determined by measuring the AP activity and was then 
converted in nM.  
 
Dendritic spine analysis  
For the assessment of dendritic spines in vitro, neurons were cultured on glass coverslips 
for 21 days in vitro (DIV) to allow robust spine formation. Between DIV6 and DIV8, 
neurons were transfected with pCIG2-ires-EGFP–expressing plasmids to visualize 
neuronal morphology. At DIV21, neurons were treated with 5nM AP-Sema3F or AP 
control for 6 hours at 37ºC. After treatment, neurons were processed for 
immunofluorescence according to the protocol described above.  
Image acquisition and spine counting in vitro and in vivo: EGFP-expressing neurons 
were imaged with an upright confocal microscope (Zeiss, LSM 700) with the acquisition 
of Z-stacks. For spine analysis, the 3D projection of each neuron was calculated with 
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Image J. Upon setting the appropriate pixel-to-µm scale, the line tool was used to draw a 
segmented line starting and extending distally from the cell body, across the main 
dendrite in vitro and the apical dendrite in vivo. For spine analysis of cortical neurons in 
vitro and in vivo, all spines (stubby, mushroom, filopodia-like) were counted along the 
proximal 50 µm extending distally from the cell body.  
 
Npn2-/- rescue in vitro: E14.5 Npn2-/- primary cortical neurons were cultured and, at 
DIV8, they were transfected with ires-EGFP plasmids expressing aminoterminally flag-
tagged Npn-2. These included WT and various CS point mutants of Npn-2. Neurons were 
cultured for an additional 13 days (for a total of 21 DIV) to allow strong protein 
expression and complete spine formation. At DIV 21, neurons transfected with each of 
the indicated plasmids were treated for 6 hours with 5nM either Sema3F-AP or AP 
control. After treatment, neurons were fixed and subjected to immunofluorescence with 
antibodies specific to GFP for dendritic process and spine visualization and to Npn-2 to 
visualize and confirm Npn-2 expression. 
 
Plasmids 
Flag-tagged Npn-1 and Npn-2 were subcloned in a backbone vector containing the 
preprotrypsin signal peptide followed by the flag epitope. The Npn-1 or Npn-2 coding 
sequences were then cloned downstream and in frame with these elements. Cysteine-to 
serine point mutants were generated by amplification of the WT protein with various 
reverse primers, each containing the desired mutation. These plasmids were subcloned in 
a pCIG2-ires-EGFP backbone vector. pHluorin-tagged Npn-2 plasmids were generated 
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by cloning in frame and with a 5’→3’ direction the endogenous signal peptide of Npn-2, 
the pHluorin coding sequence and the Npn-2 coding sequence downstream of its signal 
peptide. The PCR products were ligated using the EcoRV and SmaI sites in a pCAGGS-
dsRED express backbone vector. All plasmids were fully sequenced and rigorously tested 
with respect to their expression in cell lines and neurons. 
 
In utero electroporation  
In utero electroporation of mouse embryos was performed on E13.5 embryos of timed-
pregnant females according to (Saito, 2006). Briefly, a small vertical incision was made 
on the abdominal cavity and embryos were gently pulled out. DNA was microinjected in 
the lateral ventricle with a fine and polished glass capillary tube placed in a mouth-
controlled pipette. DNA injection was followed by the administration of 5 electric pulses 
with forceps-type electrodes, according to the following scheme: 5 pulses of 33 mV, 50 
ms each, inter-pulse interval of 950 ms. Occasionally, PBS containing 1x 
penicillin/streptomycin was poured onto the embryos to avoid drying of the embryos’ 
tissue. Operated pregnant females were kept on a slide warmer until complete recovery 
and they were later placed back in their room.     
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Figure 3. Npn-1 and Npn-2 exhibit distinct cell surface distribution that is abolished 
by a palmitoylation inhibitor. 
COS7 cells were transfected with flag-tagged WT Npn-1 or WT Npn-2. Two days after 
transfection, cells were processed for live staining with a flag antibody to detect cell 
surface neuropilins. (A, D) Steady state Npn-1 and Npn-2 cell surface distributions. 
Notably, Npn-1 is diffuse (A), whereas Npn-2 is highly clustered (D). (B, C, E, F) COS7 
cells expressing either Npn-1 or Npn-2 were treated with 10 µM or 50 µM 2-















































applied (B, C). On the contrary, 2-bromopalmitate treatments have a dramatic effect on 
Npn-2 surface protein, exhibiting a switch from clustering to diffusion (E, F). (G) Cells 
are assigned to four different categories according to whether protein is diffuse (1) 
(example: panel A), rather diffuse (2), rather clustered (3), clustered (4) (example: panel 
D). At least 20 cells were used for quantification for each condition depicted in the graph. 
Pooled data are presented as the fraction of cells (compared to the total number of cells 
quantified) exhibiting a specific type of protein distribution. Scale bar: 15 µm. 
  
57
Figure 4. Neuropilins are S-palmitoylated in vitro and in vivo. 
(A) Amino acid sequence of Npn-2 and Npn-1, including their transmembrane 
(underlined) and cytoplasmic domains. Cysteine residues are shown in bold red. (B, C) 
Palmitoylation was assessed with the ABE palmitoylation assay, in which samples were 
split in two halves and were treated either with hydroxylamine-containing buffer (+HA) 
or control buffer containing Tris (-HA). The latter serves as an internal negative control. 
These experiments showed that Npn-2 and Npn-1 are S-palmitoylated in E14.5 DIV 28 
WT primary cortical neurons (B) and in the mouse brain, both in the embryonic cortex 
(E14.5) and in adulthood (C). PSD-95 is used as a positive palmitoylation control, 
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in the +HA samples and the absence of signal in the –HA samples for neuropilins and 
PSD-95. This shows that neuropilins are indeed S-palmitoylated.  
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Figure 5. Npn-2 and Npn-1 are enriched in lipid rafts in the mouse brain. 
(A, B) Lipid rafts (or detergent-resistant membranes) were isolated from adult mouse 
whole brain. The lipid raft fraction appears as a white opaque layer, marked with a red 
asterisk (A). Samples were analyzed by SDS-PAGE and immunoblotting with antibodies 
directed against Npn-2, Npn-1, the lipid raft marker flotillin-1 and actin (B). Flotillin-1 is 
particularly enriched in lipid rafts, confirming that the fraction 5 is the lipid raft fraction 
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Figure 6. A structure-distribution analysis to identify determinants of Npn-2 
clustering.  
(A) Schematic of flag-tagged Npn1/Npn2 chimeric receptors that were generated. Each 
neuropilin consists of an ectodomain, a transmembrane domain and a cytoplasmic 
domain. The name of each chimeric neuropilin receptor is shown as a/b/c, where “a” is 
the ectodomain, “b” is the transmembrane domain and “c” is the cytoplasmic domain. 
(B) COS7 cells were transfected with these chimeras and then processed for live staining 
with a flag antibody that recognizes cell surface protein. Representative images are 
shown for each mutant protein. The top two panels show WT Npn-1 and Npn-2, which 
exhibit completely different distributions and as used as reference for the assessment of 







the cytoplasmic domains. This reveals that the transmembrane and cytoplasmic domains 
dictate Npn-1 and Npn-2 distribution. To narrow down the domain that determines the 
divergent Npn-1 and Npn-2 distributions, two chimeras were tested in which only the 
transmembrane domain of each neuropilin was swapped with that of the other (bottom 
two panels). Npn-1 that harbors the transmembrane domain of Npn-2 becomes clustered, 
whereas Npn-2 that has the transmembrane domain of Npn-1 appears diffuse. These 
findings point toward a critical role of the transmembrane domain of each neuropilin in 
determining the pattern of protein distribution. 
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Figure 7. Select Npn-2 cysteines are required for surface Npn-2 clustering in vitro. 
(A-D) COS7 cells were transfected with flag-tagged Npn2 plasmids and were then 
subjected to live staining with a flag antibody to visualize surface Npn-2. WT Npn-2 (A) 
and the C-terminal CS Npn-2 (C922S/C923S) (C) are distributed as multiple discrete 
puncta. In marked contrast, the mutation of the membrane-proximal cysteines abolishes 
Npn-2 clustering. (E) Cells are qualitatively assigned to four different categories 
according to the extent of Npn-2 clustering, according to the following scheme: 1 = 
diffuse, 4 = punctate, 2 = rather diffuse, 3 = rather punctate. Representative images for 
each of these categories are shown in E. (F) Cumulative data are presented as the fraction 
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Figure 8. Npn-1 and Npn-2 exhibit distinct but overlapping palmitoylation patterns. 
N2A cells were transfected with various Npn-2 or Npn-1 plasmids and two days after 
transfection they were subjected to ABE for the assessment of palmitoylation. (A, B) 
Npn-2 mutants were assessed for their palmitoylation. The palmitoylation signal is equal 
to the ratio of the palmitoylated (+HA) to the total protein (Input). WT is considered as 1 
(100%) and all the other Npn-2 plasmids are expressed as a percentage of the WT. (C, D) 




































































Figure 9. Neuropilins are enriched in the Golgi apparatus and the Npn-2 
membrane-proximal cysteines are required for Npn-2–Golgi association.  
(A) Golgi isolation was performed from adult mouse whole brain lysates. Six fractions 
were collected and samples were immunoblotted with Npn-2, Npn-1 or GM130 
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GM130, at the interface of the sucrose layers 1.1M and 1.2M. Both Npn-2 and Npn-1 are 
highly enriched in the cis-Golgi fraction. (B, C) E14.5 DIV13 WT primary cortical 
neurons were stained for endogenous Npn-2 (panel B, green, goat antibody) or Npn-1 
(panel C, green, goat antibody) and GM130 (magenta, rabbit antibody). Npn-2 and Npn-1 
display a strong association with the GM130-labeled Golgi apparatus in the perinuclear 
area (somatic Golgi) as well as in the dendritic shaft (Golgi outposts, prominent in panel 
B). (D, E) Npn2-/- primary cortical neurons were cultured at E14.5 for a total of 17 days 
in vitro. At DIV8 they were transfected with the indicated pHluorin-tagged Npn2–
expressing plasmids. Immunofluorescence against GFP (chicken antibody, to detect 
exogenous Npn-2) and GM130 revealed that the C-terminal cysteines are dispensable for 
Npn-2–Golgi association, whereas the membrane-proximal Npn-2 cysteines are required 
for Npn-2 localization on Golgi membranes (D). (E) The association of Npn-2 with 
GM130 is shown as the fraction of the GM130-identified Golgi that is associated with 
Npn-2. This is equal to the ratio of the Npn-2/GM130 colocalization (calculated with the 
image J colocalization plugin) to the total Golgi detected with GM130. Scale bar: (B, C) 
5 µm, (D) 10 µm. Statistics: t-test, * p < 0.05, ** p < 0.01, ns = not significant.     
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Figure 10. Effects of cysteine residues on cell surface Npn-2 distribution and 
trafficking in cortical neurons.   
(A, B) Primary cortical neurons were transfected with pHluorin-tagged Npn-2 plasmids 
and subjected to FRAP analysis at an inverted LSM 700 microscope. (A) An image of a 
transfected neuron was taken before the FRAP image sequence (prescan) and a region-of-
interest (ROI) was selected for bleach (delineated with a red circle). Then, the same 
neuronal area was imaged with the FRAP protocol, according to which images were 
taken before bleach (prebleach), immediately after bleach (bleach) and various time 
points after bleach (post-bleach) for monitoring fluorescence intensity over time for a 




























































neurons (WT: n = 7, C878S/C885S/C887S: n = 8) are presented as relative fluorescence. 
This fluorescence has been corrected for background fluorescence as well as fluorescence 
decay resulting from time-lapse imaging. (C, D) Primary cortical neurons were 
transfected with pHluorin-tagged Npn-2 plasmids and imaged live with an inverted LSM 
700 microscope (Zeiss) to visualize the distribution pattern of cell surface Npn-2. Npn-2 
WT is clustered on the neuronal surface (multiple puncta). In marked contrast, the 
mutation of the three membrane-proximal Npn-2 cysteines dramatically changes this 
punctate distribution and renders Npn-2 diffusely distributed along the dendritic shaft and 
at the cell body (C). This is qualitatively quantified in panel D, where the neurons are 
classified as having diffuse (1), rather diffuse (2), rather punctate (3) or punctate (4) 
distribution. Scale bar: 5 μm. 
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Figure 11. Select Npn-2 cysteine residues are required for Sema3F/Npn-2−mediated 
spine constraint in primary cortical neurons. 
(A, B) Npn2-/- primary cortical neurons were cultured at E14.5 for a total of 21 days in 
vitro. At DIV 8, neurons were transfected with various plasmids including an EGFP-
expressing plasmid and flag-tagged Npn-2-ires-EGFP–expressing plasmids. EGFP fills 
the neurons and delineates neuronal architecture including dendritic spines. The Npn-2 
plasmids included WT Npn-2 and a number of CS point mutants for the membrane-
proximal and cytoplasmic Npn-2 cysteines. At DIV 21, neurons were treated with 5 nM 
Sema3F-AP or AP for 6 hours. (A) Images of neurons expressing the indicated plasmids 
and treated with Sema3F-AP or AP. Neuronal morphology is visualized with EGFP 
immunofluorescence. Spines are counted along the proximal 50 µm of the main dendritic 
shaft, relative to the cell body. (B) Two different comparisons are shown for each of the 
tested plasmids: a. a comparison between Sema3F-AP and AP, indicated with the black 
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respond to Sema3F, and b. a comparison between the Sema3F-AP–treated neurons 
expressing WT Npn-2 and the Sema3F-AP–treated neurons expressing the indicated 
plasmid, shown with the green asterisks. The latter shows the rescue ability of each of the 
indicated mutant plasmids compared to WT Npn-2. Graph: mean ± s.e.m.; Statistics: 




Figure 12. Npn-2 palmitoylation is regulated by Sema3F and neural activity.
(A, B) E14.5 WT primary cortical neurons (CD1 background) were cultured for 12 days 
in vitro (DIV). At DIV 12, they were treated with 5 nM Sema3A-AP, Sema3F-AP or AP 
for two hours and then subjected to palmitoylation analysis with the ABE assay. 
Endogenous Npn-2 was detected with immunoblotting with a Npn-2 antibody. (C, D) WT 
primary cortical neurons were treated with tetrodotoxin (TTX), bicuculline or control 
treatment for two days (C) or two hours (D). Following treatment, ABE was performed to 
assess palmitoylation and samples were analyzed with SDS-PAGE and immunoblotting.  
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Figure 13. In vivo rescue of the Npn-2-/-–associated dendritic spine phenotype. 
(A-C) Npn2F/- embryos were electroporated in utero at E13.5 to target deep layer cortical 
pyramidal neurons. Different combinations of expression plasmids were used: pCIG2-
ires-EGFP to label Npn2F/- cortical neurons, pCIG2-ires-EGFP + Cre + LSL-tdTomato 
to excise the floxed Npn-2 allele and render single neurons Npn2-/-, flag-Npn2 WT−ires-
EGFP + Cre + LSL-tdTomato in order to test the ability of WT Npn-2 in rescuing  
the Npn2-/-–associated increased spine density phenotype, and flag-Npn2 
C878S/C885S/C887S (TCS)−ires-EGFP + Cre + LSL-tdTomato in order to test the 
ability of this Npn-2 CS point mutant in rescuing the dendritic spine density phenotype. 
(B) Images of cortical pyramidal neurons expressing EGFP and/or tdTomato and/or flag-
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tagged Npn-2 plasmids. The image of the EGFP only-expressing neuron shows EGFP 
immunofluorescence (grayscale), whereas the other images show tdTomato 
immunofluorescence (grayscale). Scale bar: 10 µm. (C) Dendritic spines are counted 
along the proximal 50 µm of the apical dendrite (relative to the cell body). Pooled data 
are presented in a column graph as a number of spines per µm; mean ± s.e.m. Statistics: t-
test, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.  
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Figure 14. Npn-2 transmembrane and cytoplasmic cysteines are not required for 
Npn-2/plexin-A3 interactions or Npn-2 homodimerization.  
(A) 293T cells were transfected with myc-tagged plexin-A3 and either pHluorin-tagged 
WT Npn-2, pHluorin-tagged CS Npn-2 or backbone vector. Immunoprecipitation of Npn-
2 was performed with a GFP antibody. A myc immunoblot showed that plexin-A3 is co-
immunoprecipitated with both WT and CS Npn-2. Thus, the transmembrane/membrane-
proximal Npn-2 cysteines are not required for Npn-2/plexin-A3 association in 293T cells. 
(B) 293 T cells were transfected with flag-tagged WT Npn-2 and either pHluorin-tagged 
WT Npn-2 or pHluorin-tagged CS Npn-2 or backbone vector. Flag-tagged WT Npn-2 
was immunoprecipitated with a flag antibody and samples were immunoblotted with a 
flag antibody to confirm the immunoprecipitation. An immunoblot with a GFP antibody, 
which detects pHluorin, showed that both WT and CS pHluorin-tagged Npn-2 proteins 





























DISTINCT PALMITOYL ACYLTRANSFERASES CONVEY SPECIFICITY TO 




Palmitoylation is the most common of the thioesterification reactions that occur on 
cysteine residues, and it leads to modification of the cysteine’s thiol group (-SH) and is 
catalyzed by enzymes harboring the Asp-His-His-Cys (DHHC) cysteine-rich domain 
(CRD) known as palmitoyl acyltransferases (PATs, hereafter referred to as DHHCs). The 
DHHC signature sequence is conserved and catalytically required for palmitoylation 
performed by these enzymes. DHHCs were originally described in the yeast S. cerevisiae 
(Lobo et al., 2002; Roth et al., 2002, 2006). In the human and mouse genomes 23 distinct 
DHHCs encoded by separate genes have been identified thus far. Since there are many 
more palmitoylated proteins than DHHC enzymes, it is not surprising that DHHCs 
exhibit overlapping, yet distinct, substrate specificity (Huang et al., 2009; Roth et al., 
2006). The investigation of the roles that DHHC enzymes play in vivo through the 
generation and assessment of knockout mice reveals essential roles for certain DHHCs in 
the proper development and function of select neuronal populations in the mouse brain. 
For example, there is increasing evidence showing that genetic deficits in select DHHC 
enzymes lead to improper function of proteins associated with neural diseases such as 
Huntington’s disease (Yanai et al., 2006), aberrant neuronal phenotypes in a number of 
CNS structures (Mukai et al., 2008, 2015) and profound behavioral and cognitive deficits 
(Mansouri et al., 2005; Milnerwood et al., 2013; Mukai et al., 2004; Raymond et al., 
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2007; Singaraja et al., 2011; Sutton et al., 2013). These studies, therefore, reveal novel 
major players in the largely unexplored processes of neuronal development and synaptic 
transmission, and they demonstrate the importance of DHHC-mediated protein 
palmitoylation for proper CNS function. However, in most cases the neuronal 
palmitoylated substrates that account for these structural and behavioral phenotypes have 
yet to be identified. Indeed, this is a major area of investigation. 
     Here, we identify certain DHHC enzymes, DHHC15 and DHHC8, as critical 
regulators of Npn-2 and Npn-1 palmitoylation and function, respectively. We show that, 
despite the known overlapping specificities of mammalian DHHCs for their substrates, 
there are unique patterns of DHHC-substrate specificity shown by these two PATs in 
vitro and in vivo that are critical for the functional diversification and specification of 
responses to neuronal cues. This DHHC enzyme-substrate pair specificity serves as a 
simple molecular code underlying, at least in part, the functional specificity imparted by 





Npn-2 is a DHHC15 palmitoyl acyltransferase substrate 
	
To identify palmitoyl acyltransferases that catalyze Npn-2 palmitoylation, we performed 
a screen for DHHCs with the capability of enhancing baseline Npn-2 palmitoylation in 
293T cells following the co-expression of Npn-2 with each of the 23 mammalian 
DHHCs, extrapolating from the approach taken by M. Fukata and colleagues (Fukata et 
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al., 2004). This in vitro gain-of-function experiment suggested that a limited number of 
DHHCs might be involved in Npn-2 palmitoylation, one of which is DHHC15 (Figure 
15). Moreover, two other transferases, DHHC11 and DHHC14, also enhanced Npn-2 
palmitoylation to a significant extent. However, we decided to focus first on DHHC15 
because mice harboring null mutations in DHHC11 and DHHC14 are not available and 
so would not accommodate loss-of-function studies in vivo. Moreover, DHHC15 also 
enhances the baseline palmitoylation of PSD-95 (Fukata et al., 2004), and this raises the 
possibility that it palmitoylates other synaptic proteins, too. Importantly, the DHHC15 
null mouse has been generated by Dr Tao Wang’s laboratory (Johns Hopkins University) 
and was generously provided to our laboratory. This genetic tool has been of great 
importance to our study, and here we provide compelling evidence that Npn-2, but not 
Npn-1, is a palmitoyl substrate of DHHC15. 
     DHHC15 is strongly expressed in the cerebral cortex and in a number of other tissues, 
as demonstrated by immunoblotting of lysates derived from various mouse tissues using a 
DHHC15-specific antibody generated by Drs. Mejías-Estèvez and T. Wang (Figure 16).  
     To investigate whether Npn-2 is a palmitoyl substrate of DHHC15 in cortical neurons, 
we cultured E14.5 DHHC15-/- and WT C57BL6 primary cortical neurons for a total of 12 
days in vitro and then performed ABE assays to assess palmitoylation levels of 
endogenous Npn-2. Importantly, the DHHC15-/- null mouse line has been crossed with 
C57BL6 mice at least ten times, allowing us to use WT C57BL6 mice/neurons as a 
control for our biochemical assays and phenotypic analyses. Interestingly, in the absence 
of DHHC15, Npn-2 palmitoylation is significantly reduced in cultured cortical neurons 
(by ~46%) (Figure 17, panels A and B). On the other hand, Npn-1 palmitoylation is not 
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affected (Figure 17, panels C and D). These data suggest that Npn-2 is a palmitoylation 
substrate of DHHC15 in cortical neurons, but apparently Npn-1 is not.  
 
DHHC15 is required for proper Sema3F/Npn-2–mediated spine constraint, but not 
for Sema3A/Npn-1–induced dendritic elaboration in cortical neurons 
	
To investigate whether DHHC15 plays a role in Sema3F/Npn-2–mediated dendritic spine 
constraint, we assessed DHHC15-/- primary cortical neurons for their response to 
Sema3F. Specifically, E14.5 DHHC15-/- primary cortical neurons were transfected at 
DIV8 with EGFP in order to visualize neuronal morphology, and they were then cultured 
for a total of 21 days in vitro to allow for the elaboration of mature and fully developed 
spine phenotypes. At DIV21 neurons were treated with 5nM Sema3F-AP or AP alone for 
6 hours and then subjected to immunofluorescence to assess dendritic spine density. WT 
C57BL6 cortical neurons responded to Sema3F with spine collapse responses comparable 
to those observed in the AP control (Figure 18, panels A-C). Interestingly, DHHC15-/- 
cortical neurons exhibited no spine constraint in response to Sema3F treatment (Figure 
18, panels D-F). Importantly, neurons lacking another palmitoyltransferase, DHHC8, 
which were treated as a control, responded to Sema3F with a spine collapse (Figure 18, 
panels G-I), similar to the WT neurons. The lack of Sema3F-mediated spine constraint, 
in conjunction with the decreased Npn-2 palmitoylation in DHHC15-/- neurons, together 
strongly suggest that DHHC15-mediated Npn-2 palmitoylation is required for Npn-2 to 
function in response to Sema3F as a negative regulator of spine density in cortical 
neurons.  
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     Since DHHC15 is critical for Sema3F/Npn-2 signaling in vitro, we sought to address 
whether DHHC15 is also required for Sema3A/Npn-1 signaling in cortical neurons. 
Sema3A/Npn-1 signaling promotes the elaboration of basal dendritic arbors in WT 
cortical neurons (Gu et al., 2003; Tran et al., 2009). Given this robust and highly 
penetrant phenotype, I developed an assay in which WT E14.5 primary cortical neurons 
at DIV12 are treated with 5nM Sema3A-AP or AP alone for 6 hours, and dendritic 
elaboration is assessed using immunofluorescence against the somatodendritic marker 
Microtubule-Associated Protein 2 (MAP2). WT cortical neurons robustly respond to 
Sema3A by enhanced elaborating their perisomatic dendrites (Figure 22, panels A-C), 
which corresponds to the basal dendritic domain of deep layer cortical neurons in vivo. 
Notably, DHHC15-/- neurons also respond to Sema3A to the same extent that WT 
neurons do (Figure 22, panels G-I), showing that DHHC15 is dispensable for 
Sema3A/Npn-1–mediated basal dendritic arbor complexity in cortical pyramidal neurons 
in culture. This is in accordance with the ABE assay showing that Npn-1 is not a major 
palmitoyl substrate of DHHC15 (Figure 17, panels C and D).  
     To test whether DHHC15 also plays a role in Sema signaling in vivo, we characterized 
the dendritic elaboration and spine density of DHHC15-/- deep layer cortical pyramidal 
neurons in the mouse brain. Given that Sema3F-/- and Npn2-/- mice also display an 
aberrant spine phenotype in the dentate gyrus granule cells, I also examined the spine 
density of DHHC15-/- dentate gyrus granule cells. To achieve this I used two strategies: 1) 
Thy1-GFP labeling of cortical neurons–DHHC15-/- mice were crossed with the Thy1-
GFP (Myp) mouse line that robustly labels deep layers of the cerebral cortex, dentate 
gyrus granule cells and other cell populations; and 2) Golgi staining, which provides 
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strong but sparse labeling of neurons in vivo. As far as basal dendritic arbor elaboration is 
concerned, DHHC15-/- layer V cortical neurons labeled with Golgi staining exhibit no 
defect as compared to WT C57BL6 controls (Figure 23). This supports the idea that 
Npn-1 is unlikely to be a major substrate of DHHC15.  
     On the other hand, we analyzed the dendritic spines on deep layer cortical neurons in 
these mice with Thy1-GFP and Golgi staining. Interestingly, the dentate gyrus granule 
cells of the DHHC15 null brains display a higher spine density compared to the WT 
dentate gyrus granule cells with both Thy1-GFP labeling (Figure 19, panels C and D) 
and Golgi staining (Figure 19, panels E and F). In the cerebral cortex, Thy1-GFP 
labeling has shown a modest difference in one out of two brains analyzed so far, and 
cumulative data are inconclusive (Figure 19, panels A and B, no significant difference 
thus far). However, more experiments are currently being performed in order to obtain 
definitive evidence about dendritic spines in layer V cortical neurons in vivo.      
     Taken together, these data demonstrate that DHHC15 is involved in the Sema3F 
signaling pathway, but not in the Sema3A pathway, with respect to regulating dendritic 
morphology and dendritic spine density, and therefore these experiments uncover 
functional differences between Sema3F and Sema3A by means of differential effects by 
DHHC enzymes on their co-receptors Npn-2 and Npn-1, respectively.  
 
DHHC15 is not required for anterior commissure or cranial nerve development 
	
Npn-2 is required for the proper formation of the anterior commissure (ac), as shown by 
the severely defective (largely absent) anterior commissure in the brains of Npn-2 null 
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mice (Giger et al., 2000). This prompted us to assess the anterior commissure in the 
brains of DHHC15 homozygous mutant mice. Three DHHC15-/- and WT brains were 
sectioned and the sections were stained with neurofilament antibody (2H3) to visualize 
the ac. All DHHC15-/- brains examined have normally developed anterior commissures 
(Figure 20), ruling out the possibility that DHHC15-mediated Npn-2 palmitoylation is 
required for the development of this Npn-2–dependent axonal tract. 
     In addition, Npn-2 is also required for the development of a number of cranial nerves, 
including the trochlear nerve (IV) and the proper fasciculation of the oculomotor, 
trigeminal and facial nerves (Giger et al., 2000). To assess whether DHHC15-dependent 
Npn-2 function is required for this developmental process, I analyzed the cranial nerves 
of E11.5 embryos using whole-mount neurofilament (2H3) staining. Of note, all 
DHHC15-/- embryos had properly developed cranial nerves (Figure 20). 
     Taken together, DHHC15-mediated Npn-2 palmitoylation is not required for the 
development of the Npn-2–associated axonal tracts and therefore apparently plays no role 
in Sema3F-mediated axon guidance. Current experiments are addressing whether 
Sema3F pruning functions (Riccomagno and Kolodkin, 2015) are independent of 
DHHC15. 
 
Npn-2 localization in DHHC15-/- primary cortical neurons  
	
These data on the responsiveness of DHHC15-/- cortical neurons to the secreted 
semaphorin ligand Sema3F raise several questions about aspects of neuropilin trafficking 
are defective in these neurons and lead to the phenotypic defects. First, we assessed the 
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localization of Npn-2 in the Golgi apparatus with immunofluorescence, since WT Npn-2 
is highly enriched in the Golgi. This experiment showed that endogenous Npn-2 is 
associated with the Golgi apparatus in DHHC15-/- mutants (Figure 21, panel A).  
     Second, we assessed the distribution of pHluorin-tagged WT Npn-2 transfected into 
DHHC15-/- cortical neurons with live imaging. However, Npn-2 is punctate in these 
neurons, similar to its distribution in WT neurons (data not shown).  
     Third, Sarah Mitchell isolated PSDs from wild type and DHHC15-/- primary cortical 
neurons to look for a potential redistribution of Npn-2 in different subcellular fractions. 
Two experiments performed thus far have shown a variable defect for Npn-2; 
specifically, in DHHC15-/- neurons Npn-2 exhibits variable increases in the S2 (soluble 
cytoplasmic fraction), which however is also observed for Npn-1. Importantly, one of the 
two experiments also revealed a complementary decrease of Npn-2 in the P2 (membrane) 
fraction, which was not observed for Npn-1 (Figure 21, panels B-E, one experiment 
shown). If this is true, and additional experiments are underway to investigate this issue, 
this is an important finding because it would show that DHHC15-mediated Npn-2 
palmitoylation is essential for the proper distribution of Npn-2 in the membrane and 
soluble subcellular fractions, a basic property resulting from the proper palmitoylation 
status of palmitoyl substrates.    
 
Differential Npn-2 cysteine requirements for selective palmitoyltransferase binding 
	
Palmitoylated substrates associate with their respective enzymes and palmitoylated 
cysteine residues are required for such an association (Huang et al., 2009). Thus, we 
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sought to assess potential binding of Npn-2 to the palmitoyltransferase DHHC15. We 
performed co-immunoprecipitation experiments between Npn-2 and DHHC15, and also 
Npn-1 and DHHC15, and we found that both neuropilins associate with DHHC15 
following their co-expression in 293T cells (data not shown). We also performed control 
co-immunoprecipitation experiments between Npn-2 and DHHC8 and between Npn-1 
and DHHC8. These experiments also showed no specificity, since both Npn-1 and Npn-2 
associated with DHHC8 (data not shown). These findings are consistent with data 
showing that the physical interactions between DHHC enzymes and palmitoyl substrates 
are promiscuous, in that they do not exhibit stereoselectivity and are not driven by a 
consensus sequence (Rocks et al., 2010). However, when substrates were tested for their 
palmitoylation by various co-expressed palmitoyltransferases, remarkable specificity was 
observed (Huang et al., 2009). These observations are consistent with our data showing 
that physical associations between neuropilins and DHHCs 15 and 8 are not specific but, 
with respect to the palmitoylation, Npn-2 (but not Npn-1) is a substrate of DHHC15.  
     To further investigate potential interaction specificity between neuropilins and 
DHHCs, in collaboration Sarah Mitchell we tested the association between DHHC15 or 
DHHC8 and various Npn-2 proteins, including WT, the C878S/C885S/C887S (TCS), the 
C922S/C923S (C-terminal) and the C878S/C885S/C887S/C897S/C922S/C923S (full CS 
mutants. All Npn-2 proteins associated with DHHC8 (data not shown). However, when 
DHHC15 was co-expressed with these Npn-2 proteins, WT Npn-2 associated robustly 
with the DHHC15, but the C878S/C885S/C887S and the full CS Npn-2 mutant proteins 
displayed little or no interaction with DHHC15, respectively. Importantly, the Npn-2 C-
terminal cysteines are not required for the DHHC15−Npn-2 association (data not shown; 
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experiments in progress). This finding is potentially of great importance because it 
suggests a specific requirement for the Npn-2 membrane-proximal cysteines in 
DHHC15−Npn-2 association and subsequently in DHHC15-mediated Npn-2 
palmitoylation. This observation is consistent with published observations which have 
shown that the palmitoylated cysteine residues are required for the interaction of a 
palmitoyl substrate with its palmitoyltransferases (Huang et al., 2009). We are now 
performing additional experiments to address whether there is a similar requirement for 
the association between Npn-1 and DHHC8, given that Npn-1 is a likely substrate of 
DHHC8 (see next section below).   
 
DHHC8 is essential for Sema3A/Npn-1–induced dendritic elaboration but not for 
Sema3F/Npn-2–induced spine collapse    
	
Another DHHC enzyme of critical importance for the development of the central nervous 
system is DHHC8 (also known as ZDHHC8). In particular, DHHC8 promotes the 
dendritic elaboration and spine formation of hippocampal pyramidal neurons in vitro and 
in vivo (Mukai et al., 2008). The dendritic hippocampal phenotype of DHHC8-/- neurons 
closely resembles the reduced dendritic elaboration phenotype resulting from the genetic 
abolition of the Sema3A/Npn-1 signaling in cortical neurons observed in the Npn1Sema3A- 
mouse (Gu et al., 2003). Given this striking similarity, I sought to investigate whether 
Npn-1 is a substrate of DHHC8 in the cortex. I first analyzed the dendritic arborization of 
DHHC8-/- or WT C57BL6 deep layer cortical pyramidal neurons with Golgi staining. 
This revealed a severe dendritic arborization defect of DHHC8-/- neurons, which 
exhibited significantly reduced basal dendritic arborization (perisomatic) compared to the 
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WT neurons (Figure 23). This shows that the DHHC8 null mouse phenocopies the 
abolition of Sema3A/Npn-1 signaling in deep layer cortical neurons (Gu et al., 2003; 
Tran et al., 2009) and raises the possibility that Npn-1 is a substrate of DHHC8 in the 
cortex. To test this hypothesis, and to determine whether DHHC8 and Npn-1 function in 
the same or in parallel pathways, we tested the responsiveness of DHHC8-/- cortical 
neurons to Sema3A. Treatment of WT cortical neurons with Sema3A-AP results in a 
more elaborate dendritic arbor as compared to the AP treatment alone (Figure 22, panels 
A-C). If DHHC8 is not required for Sema3A/Npn-1 signaling, DHHC8-/- neurons should 
respond to Sema3A. On the contrary, if DHHC8-mediated Npn-1 palmitoylation is 
required for proper propagation of the Sema3A/Npn-1 signaling, then DHHC8-/- neurons 
are not expected to respond to Sema3A. We therefore treated DHHC8-/- with Sema3A-AP 
or AP alone and assessed basal dendritic elaboration in these neurons with MAP2 
staining. Remarkably, DHHC8-/- neurons were unable to respond to Sema3A (Figure 22, 
panels D-F), suggesting that DHHC8 is required for Npn-1 function and that Npn-1 is a 
physiological substrate of DHHC8. To provide additional support for the hypothesis that 
Npn-1 is a substrate of DHHC8 in cortical neurons, I assessed Npn-1 palmitoylation in 
WT and DHHC8-/- neurons using ABE. Thus far, these experiments have been 
inconclusive, however additional ABE experiments are currently underway to assess 
DHHC8 activity, both in cell culture models and in the mouse brain. 
     Taken together, these findings suggest that Npn-1 is palmitoylated by DHHC8 in 
cortical neurons, and that this modification is required for Sema3A/Npn-1–induced 
dendritic arborization of these neurons. 
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     To investigate whether this effect of DHHC8 is specific for Npn-1 as opposed to Npn-
2, we assessed the responsiveness of DHHC8-/- cortical neurons to Sema3F by assessing 
their spine density after control AP or Sema3F-AP treatment. Importantly, DHHC8-/- 
neurons robustly respond to Sema3F with a decrease in their spine density. Furthermore, 
we assessed the spine density of deep layer cortical pyramidal DHHC8-/- neurons in vivo 
with Thy1-GFP. Interestingly, DHHC8-/- deep layer cortical pyramidal neurons exhibit 
significantly reduced spine density as compared to WT neurons, demonstrating that 
DHHC8 is required for spine formation or maintenance (Figure 24). This makes it 
unlikely that Npn-2 is a substrate of DHHC8, since the Npn2-/- mice display the opposite 
phenotype. This finding is in agreement with the role that DHHC8 plays in hippocampal 
pyramidal neurons (Mukai et al., 2008).  
     In summary, DHHC8 is palmitoyl acyltransferase that apparently acts on Npn-1, but 
not in Npn-2, to regulate palmitoylation and also select aspects of neuronal morphology. 
We can therefore speculate that DHHC8 recruits to the Sema3A/Npn-1 signaling 
pathway distinct effectors that cause dendrite growth-associated changes but not 
cytoskeletal rearrangements associated with spines. However, lack of knowledge 
regarding proteins that may interact with this transferase makes any speculations with 
respect to cytoskeleton rearrangements premature. Another possibility is that Npn-1 on its 
own interacts with cytoskeletal components related to dendritic growth, perhaps as a 







My work identifies palmitoylation as a post-translational modification critical for the 
functional specification and diversification of neuropilin receptors by means of palmitoyl 
acyltransferase-substrate specificity. These data are summarized in a schematic model 
(Figure 25). My study is one of the first, along with work from J. Gogos (Mukai et al., 
2008, 2015), to demonstrate effects of palmitoyl acyltransferases on select aspects of 
neuronal morphology. Interestingly, I also identified specific neuronal protein substrates 
for these enzymes and I show that this specificity critically directs distinct aspects of 
neuronal morphology, ultimately contributing to the establishment of neuronal polarity. 
Of course, the phenotypes resulting from deletion of a palmitoyl acyltransferase 
constitute the net effect of the lack of palmitoylation of all substrates of this transferase. 
Therefore, if a DHHC knockout mouse phenocopies a specific mutant mouse, this raises 
the question as to whether these two proteins act in parallel or the same signaling 
pathway. Here, we provide two lines of evidence supporting the notion that Npn-1 
functions in same pathway as DHHC8, and that Npn-2 functions in the same pathway as 
DHHC15. First, neuropilin palmitoylation is reduced in the respective DHHC loss-of-
function neurons, showing that each neuropilin is a substrate of each specific DHHC 
enzyme.  Second, DHHC KO cortical neurons do not respond to the respective Sema 
ligand, suggesting direct involvement of each DHHC enzyme in one of the two specific 
Sema signaling pathways. 
     Usually more than one palmitoyl acyltransferase will palmitoylate a protein, albeit to 
varying extents (Greaves and Chamberlain, 2011; Huang et al., 2004). The screens I 
performed suggest that baseline neuropilin palmitoylation is enhanced by a few different 
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palmitoyl acyltransferases. A challenging question to address is how deletion of a single 
palmitoyl acyltransferase, which causes a limited decrease in a specific protein’s 
palmitoylation levels, leads to a specific inability to function properly. A plausible 
explanation would be that, upon loss of a palmitoyl acyltransferase, fewer protein 
molecules are palmitoylated and therefore there a severe imbalance develops in how that 
substrate protein is trafficked and functions. Another theory could be that of a "dominant" 
palmitoyl acyltransferase. Specifically, different palmitoyl acyltransferases might 
palmitoylate a protein on different cysteines and in distinct subcellular compartments. 
This could result in different palmitoylation events being important for distinct protein 
functions. For example, a palmitoylation event close to the plasma membrane might 
regulate the targeting of the protein to nearby dendritic spines, its insertion into a specific 
plasma membrane microdomain, or it might mediate activity-dependent protein targeting 
(Brigidi et al., 2014a; Fukata et al., 2013; Noritake et al., 2009). Such an event, even if it 
is quantitatively small and the bulk palmitoylation of the protein is not affected, could 
result in defects that affect proper distribution and function of a protein since at any one 
time only a small fraction of total protein might be functionally significant. However, in 
order to provide more insight into the trafficking and distribution of palmitoylated 
proteins in distinct subcellular compartments specific antibodies against palmitoylated 
proteins will have to be developed, with the goal of visualizing at a high resolution 
protein palmitoylation on specific residues, as has been previously shown for PSD-95 
(Fukata et al., 2013). Specifically, Fukata and colleagues isolated an antibody that 
specifically recognized the conformation of palmitoylated PSD-95 by screening an 
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antibody phage display library, showing that they can specifically detect palmitoylated 
PSD-95 in neurons (Fukata et al., 2013).    
     Importantly, the implication of several palmitoyl acyltransferases in disease 
pathogenesis in the nervous system (Young et al., 2012) makes the identification of their 
substrates critical from a therapeutic standpoint. DHHC15 has been implicated in a case 
of a human X-linked mental retardation (Mansouri et al., 2005), whereas DHHC8 has 
been linked to the pathogenesis of schizophrenia (Mukai et al., 2004). The existence of 
specific substrates for these enzymes could provide a rationale for the development of 
targeted therapeutic approaches directed toward ameliorating the symptoms of mental 
and cognitive disorders associated with defects or loss in certain palmitoyl 
acyltransferases. However, this requires a much more extensive investigation of the 






Dendritic elaboration analysis 
Neuronal dendritic elaboration was assessed with Sholl analysis performed with Image J. 
In detail, confocal stacks of neurons were used to calculate the 3D projection, which was 
then thresholded. Any background fluorescence or neighboring neurons interfering with 
the analysis were erased with the paintbrush tool. The point-selection was placed at the 
center of the cell body and the Sholl analysis plugin was used to count the dendritic 
processes at various distances from the cell body, ranging from 0 µm to 100 µm.   
 
Spine analysis 
Described in detail in the experimental procedures of Chapter 2. 
 
Immunofluorescence (in vivo)   
Sections mounted on slides were left to dry at room temperature and then they were 
blocked with 10% goat or donkey serum + 0.1% Triton X-100 in PBS, for one hour at 
room temperature. Then tissue was incubated with primary antibodies diluted in 1% 
serum + 0.1% Triton X-100 in PBS, overnight at 4ºC. Tissue was washed three times 10 
min. each with 1x PBS. Next, tissue was incubated with secondary antibodies diluted 
1:500 for one hour at room temperature. Finally, tissue was washed four times 10 min. 
each with 1x PBS and a rectangular glass coverslip was placed with mounting medium on 
the slide with the sections. Primary antibodies: GFP, chicken IgY, 1:500 (Avés, cat. no. 
GFP-1020); MAP2, mouse, 1:1000 (Sigma, cat. no. M1406); GM-130 (AbCam, cat. no. 
ab52649); neurofilament (2H3), mouse monoclonal (Developmental Studies Hybridoma 
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Bank). Secondary antibodies: CF488A donkey anti-chicken IgY (Biotium, cat. no. 
20166); Alexa Fluor 488 goat anti-mouse IgG (Life Technologies); Alexa Fluor 555 
donkey anti-rabbit IgG (Life Technologies).  
 
Neuron labeling in vivo 
Thy1-GFP: the Thy1-GFP (m) line (MYP) was crossed to various knockout mice 
(DHHC15-/-, DHHC8-/-) for labeling of layer V cortical neurons and dentate gyrus granule 
cells. DHHC15+/-;Thy1-GFP mice were crossed with each other to generate litter- and 
age-matched WT and DHHC15-/- mice expressing Thy1-GFP. Likewise, DHHC8+/-
;Thy1-GFP mice were crossed to generate WT and DHHC8-/- mice expressing Thy1-
GFP.  
 
Golgi staining: performed with the Rapid GolgiStain kit (FD Neurotechnologies, Cat. #: 
PK401) according to the protocol provided by the kit. Briefly, brains were dissected out 
and incubated with impregnation solution A+B for a total of twelve days in the dark at 
room temperature, while impregnation solution was changed on the second day of the 
incubation. After twelve days, impregnation solution was discarded and brains were 
incubated with solution C for a total of 4 days in the dark at 4oC, while solution C was 
replaced by fresh solution C on the second day. Brains were embedded in NEG 50 
following regular procedures and sectioned with a Leica cryostat (Z5470) at the coronal 
plane, at 100µm thickness. Sections were left to dry for 24 hours in the dark and next day 
they were subjected to staining according to the protocol. Stacks of neurons were 
acquired using a DIC at an inverted LSM 700 confocal microscope (Zeiss), with a 20X 
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lens for the visualization of dendrites and with a 63X oil lens for the assessment of 
dendritic spines.  
 
Whole-mount neurofilament staining: E11.5 embryos were removed from the 
abdominal cavity of a timed-pregnant female and fixed overnight with 4% PFA at 4˚C. 
Next day, embryos were washed three times 10 min. each with PBS and gradually 
dehydrated with methanol diluted in PBS, according to the following scheme: 30% 
methanol for 1 hour, 50% methanol for 1 hour, 80% methanol for 2 hours, 100% 
methanol overnight. Endogenous peroxidase activity was quenched overnight. Incubation 
with 1x TNT, one hour each, five times. Incubation with the 2H3 neurofilament antibody 
(mouse monoclonal, Developmental Studies Hybridoma Bank) for 48 hours. Next, 
embryos were washed five times, 1 hour each, with TNT buffer and then incubated with a 
secondary antibody for 36 hours. Next, tissue was washed two times, 30 minutes each, 
overnight and two times 30 minutes each, with TBS. Signal was developed and then 
embryos were washed for 5-15 minutes with TBS. Next, tissue was fixed overnight, at 
4˚C, with 4% PFA. Tissue was dehydrated with methanol diluted in PBS, according to 
the following scheme: 30% methanol for 1 hour, 50% methanol for 1 hour, 80% 
methanol for 2 hours, 100% methanol overnight. Finally, embryos were cleared with 
BABB solution and imaged with DIC. 
 
Mice 
Animal procedures were carried out in conformity with the policies and guidelines of the 
Animal Care and Use Committee of the Johns Hopkins University, which are established 
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according to the US National Research Council’s Guide to the Care and Use of 
Laboratory Animals and in compliance with the Animal Welfare Act and Public Health 
Service Policy. WT C57BL6 mice were purchased from Jackson laboratories and WT 
CD1 mice were purchased from Charles River laboratories. The DHHC15 (or 
ZDHHC15) null mouse line was generated and provided to our lab by Dr. Tao Wang’s 
laboratory (Johns Hopkins University) and has been characterized by Rebeca Mejias-
Estevez (Rebeca Mejias-Estevez et al., unpublished). The DHHC8 (or ZDHHC8) null 
mouse was generated and provided to our lab by Dr. Joseph Gogos and colleagues 
(Columbia University) and has been previously characterized (Mukai et al., 2004, 2008). 
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Figure 15. Npn-2 is a substrate for a subset of select palmitoyl acyltransferases. 
(A, B) 293T cells were transfected with Npn-2 only or co-transfected with Npn-2 along 
with each of the 23 mammalian palmitoyl acyltransferases (DHHCs) (expression 
plasmids of DHHCs were provided by Masaki Fukata (Fukata et al., 2004). Following 
their expression, cells were subjected to the ABE assay for the assessment of Npn-2 
palmitoylation. (A) Immunoblots with Npn-2 antibody (rabbit) showing the +HA (+ 
hydroxylamine) samples (top), which represent the palmitoylated protein, and the Npn-2 
inputs (bottom). The no plasmid control sample (leftmost lane) confirms that the signal is 
specific to Npn-2 protein. (B) The average from two independent experiments is 



































































































the total protein (Input). The ratio for each sample (Npn-2 along with each of the 23 
DHHCs, red columns) is expressed as a percentage of the Npn-2 only sample (blue 
column, leftmost column in the graph). The Npn-2 only sample represents baseline Npn-2 
palmitoylation and it’s set at 100%. Graph: mean ± s.e.m. 
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Figure 16. Tissue expression and localization of the palmitoyltransferase 
DHHC15. 
(A) Tissue expression profile of DHHC15. Immunoblot using a custom rabbit 
antibody α-DHHC15 identified a 39 kD band corresponding to DHHC15 protein. The 
antibody was generated in Dr Tao Wang’s lab (Johns Hopkins). (B) Subcellular 
distribution of DHHC15. COS cells were transfected with DHHC15-myc and psd95-
GFP. Immunofluorescence was conducted using α-myc for DHHC15 (red), α-GM130 
(Golgi marker, brown), α-GFP for psd-95 (green), merged image (yellow). Note co-
localization of DHHC15 with GM130 in the Golgi apparatus. The figure is provided 
to us by courtesy of Rebeca Mejias-Estevez (unpublished data, Dr Tao Wang’s lab, 






























































Figure 17. Npn-2 is a palmitoyl substrate of DHHC15.
(A-D) Wild-type C57BL6 and DHHC15-/- primary cortical neurons (DIV12) were 
subjected to the ABE assay for the assessment of palmitoylation of endogenous proteins. 
Samples were immunoblotted with a Npn-2 (A, B) or a Npn-1 (C, D) antibody to detect 
endogenous Npn-2 or Npn-1, respectively. Palmitoylated protein is presented as the ratio 
of +hydroxylamine sample (palmitoylated) to the corresponding input. In each 
experiment, an average is calculated for the WT and this is considered as being 100% (1). 
The palmitoylation of neuropilin in DHHC15-/- is shown as a percentage of the WT. Npn-
2 palmitoylation in DHHC15-/- cortical neurons is reduced by ~ 46% (B), whereas Npn-1 
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Figure 18. DHHC15 is required for Sema3F/Npn-2−mediated spine constraint in 
vitro.  
(A-I) E14.5 WT C57BL6, DHHC15-/- or DHHC8-/- cortical neurons were transfected with 
an EGFP-expressing plasmid and cultured for a total of 21 days in vitro (DIV). At DIV 
21, they were treated with 5 nM Sema3F-AP (A, D, G) or AP control (B, E, H) for 6 
hours. EGFP immunofluorescence was performed in order to visualize neuronal 
morphology and neurons were imaged with a 63X oil immersion lens to visualize 
dendritic spines. All types of dendritic spines (mushroom, stubby, filopodia-like) were 
counted along the proximal 50 µm extending distally from the cell body. Pooled data are 
shown as a number of spines per µm (C, F, I). 
(A-C) Wild-type C57BL6 cortical neurons responded to Sema3F-AP with a constraint of 
their dendritic spines. (D-F) DHHC15-/- primary cortical neurons were not responsive to 
Sema3F-AP!
AP!
        WT C57BL6!
A!
B!
           DHHC8-/-!
H!
G!





Sema3F. (G-I) DHHC8-/- primary cortical neurons were responsive to Sema3F, similar to 
WT neurons. Statistics: t-test, mean ± s.e.m.  Statistical significance: * p <  0.05, ** p < 
0.01, ** p < 0.001, *** p < 0.0001. Scale bar: 7 µm. 
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Figure 19. Effects of DHHC15 on dendritic spines of dentate gyrus granule cells and 
deep layer cortical neurons in vivo. 
(A-D) Brains derived from WT or DHHC15-/- mice (4 weeks old) expressing Thy1-GFP 
(Thy1-GFP (m), myp), were analyzed with EGFP immunofluorescence to visualize 
neuronal morphology. Neurons, layer V cortical pyramidal neurons (A, B) and dentate 
gyrus granule cells (C, D), were imaged with the acquisition of confocal stacks and 
spines were counted along the indicated dendritic segments extending distally from the 
cell body. (A, B) Spine counts for layer V cortical pyramidal neurons labeled with EGFP 
(A) (two brains per genotype analyzed thus far; more experiments are ongoing) are 
shown in B (not significant difference). (C, D) Spine numbers for dentate gyrus granule 
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cells labeled with EGFP (C) are shown in D. (E, F) WT and DHHC15-/- brains were 
subjected to Golgi staining for sparse labeling of single neurons in vivo. Representative 
images of dentate gyrus granule cells are shown in E, and spine counts along various 
segments extending distally from the cell body are shown in F. Statistics: t-test, * p < 
0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Scale bar: 5 µm in (A), 10 µm in (C), 















Figure 20. DHHC15 is not required for the development of the anterior commissure 
or cranial nerves that require Npn-2.  
(A-A’, B-B’) Brains from WT (A, A’) or DHHC15-/- (B, B’) were sectioned (at 100 µm 
thickness) and sections were subjected to immunofluorescence with a neurofilament 
antibody (2H3) to visualize the axonal tracts. The anterior commissure, both the anterior 
branch (A, B; round structure marked with white arrows) and the midline-crossing fibers 
of the anterior commissure (A’, B’; horizontal fibers in the midline marked with white 
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arrows) are intact in all DHHC15-/- brains examined thus far (3/3).  (C, D) E11.5 embryos 
were subjected to whole-mount neurofilament staining for the visualization of cranial 
nerves. The trochlear nerve (IV; marked with a white arrow) is normally developed in 
















Figure 21. Npn-2 localization in DHHC15-/- cortical neurons.  
(A) Immunofluorescence on E14.5, DIV15, DHHC15-/- primary cortical neurons, 
transfected with GFP (fills the neuron and delineates neuronal morphology), with 
antibodies directed against endogenous Npn-2 (goat), endogenous GM130 (rabbit) 
and GFP (chicken). White arrow points to the Npn-2 and GM130 signals and to their 
colocalization. (B-E) PSD prep performed on E14.5 DIV12 WT or DHHC15-/- 
primary cortical neurons (one experiment). A number of different fractions were 
collected and samples were analyzed with SDS-PAGE and immunoblotting with 
Npn-2 (rabbit) (B, C) or Npn-1 (rabbit) (D, E) antibodies. (C, E) Different fractions 
are normalized to S1, which represents the starting material, and WT values (ratios) 
are set to 1 (100%) whereas the DHHC15-/- values are expressed as a percentage of 
the WT.  Scale bar in (A): 7 µm. 
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Figure 22. DHHC8 is required for Sema3A/Npn-1–induced basal dendritic 
elaboration in primary cortical neurons.  
(A-I) E14.5 primary cortical neurons from WT (C57BL6) (A-C), DHHC8-/-  (D-F) or 
DHHC15-/- (G-I) mouse embryos were cultured for a total of 12 days in vitro (DIV), and 
at DIV6, they were treated with 5nM Sema3A-AP or AP control for 6 hours. Dendritic 
elaboration was assessed with MAP2 immunofluorescence and quantified with Sholl 
analysis. Cumulative data from several independent experiments are presented as a 
number of intersections at various distances from the center of the cell body (C, F, I). (A-
C) WT cortical neurons respond to Sema3A with an elaboration of their dendritic arbor. 
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(D-F)  DHHC8-/- cortical neurons are not responsive to Sema3A (consistent across 
different experiments). (G-I) DHHC15-/- cortical neurons robustly respond to Sema3A, 
similar to the WT neurons. Statistics: t-test, significance: * p < 0.05. Scale bar: 16 µm.   
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Figure 23. DHHC8 is required for proper dendritic elaboration of layer V cortical 
neurons in the mouse brain.  
(A-D) WT C57BL6, DHHC15-/- or DHHC8-/- brains were subjected to Golgi staining for 
sparse labeling of neurons in vivo. Deep layer cortical neurons were imaged with the 
acquisition of stacks with a 20x lens using DIC. The Z-projection was calculated with 
image J and subsequently Sholl analysis was performed for the quantification of dendritic 
elaboration. (A-C) Representative images of WT (C57BL6), DHHC15-/- or DHHC8-/- 
deep layer cortical neurons. (D) Pooled data from different brains are presented as a 
number of intersections (between dendritic arbors and concentric circles drawn around 
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and at variable distances from the cell body) at the indicated distances from the cell body 


















Figure 24. Effects of DHHC8 on dendritic spines of deep layer cortical neurons in 
vivo.  
(A, B) DHHC8+/+;Thy1-GFP and DHHC8-/-;Thy1-GFP littermates were sacrificed and 
brains were processed for GFP immunofluorescence. GFP-expressing neurons were 
imaged by the acquisition of confocal stacks with a 63X oil immersion lens, for the 
visualization of the precise neuronal morphology including dendritic spines. (A) Panels 
show layer V cortical neurons and some spines are marked with yellow asterisks. Note 
the difference between WT and DHHC8-/-. (B) Column graph shows the mean and error 
bars represent the standard error of the mean (s.e.m.). Spines were counted along the 
proximal 50 µm of the apical dendrite, relative to the cell body. Thus far, two brains in 
total (one per genotype) have been analyzed; analysis of more brains is ongoing. Scale 
bar in (A): 10 µm. Statistical significance is assessed with a paired t-test; ** p < 0.01.    
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Figure 25. Schematic model.  
Npn-2 and Npn-1 are S-palmitoylated in vitro and in vivo. This modification is essential 
for Npn-2 association with the Golgi apparatus as well as its proper distribution on the 
cell surface (clustering). Moreover, the membrane-proximal Npn-2 cysteines, which are 
palmitoylated, are required for Npn-2 response to Sema3F in order to cause a dendritic 
spine constraint. Interestingly, Npn-2 and Npn-1 are functionally associated with 
different palmitoyl acyltransferases; DHHC15 and DHHC8, respectively. This functional 
specificity between a palmitoyltransferase and different palmitoyl substrates reveals a 
molecular mechanism by which guidance cue receptors acquire and maintain their 

























Sema3F plays an essential role in regulating the development of deep layer cortical 
pyramidal neurons, however the cell types that secrete Sema3F in the cerebral cortex 
have not been elucidated. Sema3F might be secreted by: 1) deep layer pyramidal 
neurons–in this case Sema3F would act cell autonomously (autocrine signaling); 2) 
subtypes of inhibitory neurons that lie in the vicinity of pyramidal neurons; 3) non-
neuronal cells (including glial cells and endothelial cells); and 4) any combination of 
these different cell types. The identification of the cell types that secrete Sema3F requires 
the visualization of Sema3F-expressing and Sema3F-secreting cells with single cell 
resolution in vivo.  The lack of optimal antibodies directed against Sema3F prompted us 
to generate an epitope-tagged knock-in Sema3F mouse in order to be able to perform 
high-resolution localization studies in vitro and in vivo. However, the visualization of 
Sema3F with high resolution in the cerebral cortex has not been sufficient to point toward 
a physiologically relevant source of Sema3F that accounts for the increased dendritic 
spine density phenotype observed in Sema3F mutants. To investigate this, we are 
currently using the floxed Sema3F mouse line made some time ago in the Kolodkin 
laboratory (Sahay et al., 2003) crossed to a number of different Cre lines, including: 
Rbp4-Cre (layer 5-specific), Emx1-Cre (pan-excitatory) and Dlx-5/6 Cre (pan-
inhibitory), with the goal of assessing the spine density phenotype following these cell-
type specific deletions of Sema3F to identify the role each of these cell types might play 
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in the Sema3F-/--associated phenotypes. Here, we describe the generation of the Sema3F 
knock-in mouse and our ongoing efforts to visualize Sema3F protein in the cortex and 




Generation and assessment of the Sema3F-6xMYC epitope-tagged knock-in mouse 
	
To visualize Sema3F in vivo with high resolution, I generated an epitope-tagged knock-in 
Sema3F mouse in which a 6xMYC epitope tag has been inserted in exon 2 of the Sema3F 
coding sequence, downstream of its signal peptide. A floxed NEO cassette was cloned in 
the intron between exons 2 and 3 and serves as a positive control; this was excised after 
the line underwent germline transmission (Figure 26, panels A and B). The generation 
of this mouse line is described in greater detail in the Experimental Procedures. The 
Sema3FMyc was germline transmitted and the genotype of this mouse line was assessed by 
two different PCR reactions (Figure 26, panels C and D).  
     To test this mouse for a potential disruption of Sema3F function because of the 
insertion of an epitope tag, we performed a number of experiments in which we assessed 
the integrity of axonal tracts that are dependent on Sema3F function in vivo. First, we 
assessed the embryonic cranial nerves with whole-mount neurofilament staining at E11.5. 
None of the Sema3Fmyc/myc embryos examined showed any Sema3F-/-–associated defects 
(cranial nerves IV, V, VI, VII) (data not shown). Second, we performed neurofilament 
staining on coronal brain sections of postnatal mice to assess the anterior commissure. 
This showed that the anterior commissure is normally developed in Sema3Fmyc/myc mice, 
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with no defects in its anterior or posterior branches (data not shown). These experiments 
show that this mouse line does not display Sema3F-/--associated defects and it is therefore 
a valuable genetic tool for the investigation of Sema3F distribution and function.  
     Next, we wanted to test whether the 6xMYC-tagged Sema3F protein is secreted. To 
investigate this, we cultured E14.5 primary cortical neurons derived from either 
Sema3Fmyc/myc or Sema3F+/+ embryos and let them grow in vitro for 12-15 days. Then, we 
collected the medium and concentrated it by centrifugation in a falcon tube carrying a 
100K filter (Millipore). Samples were analyzed with SDS-PAGE and immunoblotting 
with two different antibodies that recognize the myc epitope (rabbit, clone 71D10 and 
mouse, clone 9E10) was performed. Both antibodies revealed a specific signal in the 
medium from Sema3Fmyc/myc neurons that was not present in the medium of Sema3F+/+ 
neurons and that was of the molecular weight of Sema3F (Figure 26, panel E).  
     In summary, the 6xMyc-tagged knock-in mouse carries a tagged Sema3F allele that 
exhibits the properties of endogenous Sema3F and has no detectable mutant phenotypes. 
We can therefore use this tool to visualize Sema3F localization in vitro and in vivo.   
 
Localization of Sema3F protein in the mouse brain  
	
Next, we visualized the tagged Sema3F protein in mouse brain sections. Standard 
paraformaldehyde tissue processing and immunofluorescence did not give strong signal, 
perhaps because Sema3F is secreted, expressed at what we think are low levels, and 
perhaps folded in such a way that the epitope tag could be masked. To overcome these 
potential impediments, I used an alternative method for tissue processing and 
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immunofluorescence that has been previously used to visualize secreted guidance cue 
protein in vivo (Kennedy et al., 2006). This method included fixation with an organic 
solution (Carnoy’s) and paraffin embedding and sectioning. The method followed here is 
described in detail in the experimental procedures. These experiments are preliminary 
and on going. 
     Immunofluorescence on brain sections revealed robust Sema3F immunoreactivity in 
the inferior colliculus and the olfactory bulb (Figure 27, panels A-A’, B-B’). In the 
cerebral cortex, at early postnatal stages (P1), the signal is quite diffuse but seems to be 
neuron-specific (Figure 27, panels C-C’). However, at later developmental stages (P21), 
Sema3F immunoreactivity is specifically localized in deeper cortical layers, including the 
Ctip2-positive layer V (Figure 27, panels D-D’, E-E’). Our endeavors to perform at the 
same time staining with cell type-specific markers were not particularly successful 
because of the organic fixation, which caused excessive background and non-specific 
labeling of several cell types. To get around this, we generated mice that harbored the 
Sema3F-myc allele, the Dlx5/6-Cre recombinase and LSL-tdTomato in order to 
unambiguously visualize inhibitory neurons labeled with tdTomato. These efforts are 
ongoing. 
     Preliminary experiments in primary cortical cultures have shown that Sema3F is 
detected in large CamKII+ neurons (Figure 27, panel F), which represent cortical 
pyramidal neurons, but also in smaller CamKII-neurons which we find in the vicinity of 
the large CamKII+ neurons and probably represent inhibitory neurons (data not shown). 
However, this remains to be confirmed with additional in vitro and also in vivo 
experiments.  
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     The detection of Sema3F in a number of neuronal cell types makes it likely that there 
is a differential contribution of distinct neuron subtypes to the Sema3F-induced spine 
constraint. The investigation of this issue will require functional experiments in which 
Sema3F is deleted in a subset of neurons and the spine density of cortical pyramidal 
neurons in assessed in vivo. 
 
Sema3F secretion is regulated by neuronal activity 
	
This Sema3FMyc mouse line has also been used in our laboratory for the investigation of 
the mechanism by which Sema3F/Npn-2 signaling affects the synaptic scaling in neural 
networks. Qiang Wang has shown that Sema3F/Npn-2 is required for proper downscaling 
of cell surface AMPA receptors following an excessive increase in network activity. In 
more detail, following bicuculline treatment, which inhibits GABAergic transmission and 
causes increased neuronal activity, WT neurons display a downregulation of synaptic 
GluA1 in order to compensate for the aberrant activity. However, Npn2-/- neurons are not 
capable of downscaling network activity (Wang et al., unpublished observations). To 
investigate the role of Sema3F in downscaling, Dr. Wang cultured Sema3Fmyc/myc 
neurons, treated them with bicuculline and assessed the amount of secreted Sema3F in 
the culture media compared to the control treatment. Remarkably, bicuculline treatment 
caused a marked increase in secreted Sema3F, suggesting that Sema3F secretion may 
play an important role in downregulating excitatory activity, perhaps by means of its 
known role in regulating dendritic spine and excitatory synapse constraint (Wang et al., 




We have generated and characterized an epitope-tagged Sema3F6xMyc knock-in mouse, 
and our analysis shows that this mouse is an excellent genetic tool that allows for the 
detection and visualization of endogenous Sema3F in vivo with single cell resolution. 
Moreover, we have been performing functional experiments to identify the 
physiologically important cellular source of Sema3F in the cerebral cortex, taking 
advantage of our conditional Sema3F mouse line and available Cre driver lines. Finally, 
we have strong preliminary data showing that Sema3F is regulated in response to activity 
and that this is important for network activity scaling. Given the increase in Sema3F 
secretion following bicuculline treatment, which was detected using my Sema3F6xMyc 
mouse line, we can use this mouse to investigate potential increases or decreases in 
Sema3F secretion following manipulations of the neural network, including aberrant 
neural activity in genetic mouse models of epileptic activity, cognitive disorders and 









Experimental procedures  
	
Generation of the 6xMyc-tagged Sema3F knock-in mouse  
The targeting vector was made using a homologous recombination-mediated gene 
targeting strategy, as described (Liu et al., 2003). Briefly, a Sema3F BAC clone was used 
for the retrieval of a Sema3F genomic DNA sequence that included exon 2 and genomic 
sequences upstream and downstream of exon 2, which made up the long and short 
homology arms, respectively; these were cloned into the PBS-DTA vector, resulting in 
the gap-repaired plasmid. DTA encodes for diphtheria toxin A, which served as a 
negative selection marker during ES cell screening. The long homology arm consisted of 
~9,580 base pairs and extended upstream of exon 2, whereas the short arm consisted of 
1,720 base pairs and extended downstream of exon 2. Next, the 6xMYC nucleotide 
sequence was subcloned into the second exon of Sema3F, between DNA sequences 
encoding the amino acids L26 and P27, eight amino acids downstream of the predicted 
signal sequence cleavage site, which lies between P18 and A19. Subsequently, short 
genomic fragments flanking the tag insertion site were subcloned on either side of the 
epitope tag and a LoxP-NEO-LoxP (LNL) cassette was inserted 510 base pairs 
downstream of the exon 2 coding sequence. NEO, encoding for neomycin, serves as a 
positive selection marker. This constructed Sema3F genomic sequence was subcloned in 
the PL451 vector and this plasmid, known as the mini-targeting vector, carried all the 
desired modifications to be inserted in the Sema3F locus (epitope tag and NEO cassette). 
This modified genomic fragment was introduced in the Sema3F gap repaired plasmid by 
homologous recombination and led to the generation of the targeting vector. The 
targeting vector was sequenced, linearized and given to the Johns Hopkins Transgenic 
	 120 
Mouse Core for electroporation into embryonic stem cells. Plated clones were positively 
selected with neomycin, whereas diphtheria toxin A expression served as a negative 
selection for incorrect clones. The clones that were able to grow were screened using 
PCR and positive clones were further tested with karyotyping and Southern blots. Finally, 
the correct clones were injected into 129S6/SvEvTac mouse blastocysts for the 
generation of chimeric mice, and chimeras were crossed with wild type mice to obtain 
germline transmission. Progeny harboring the MycSema3F allele were crossed with CMV-
cre line (a germline Cre) for excision of the floxed NEO cassette. Mice were screened for 
mycSema3F protein expression by SDS-PAGE and Western blot analysis using cortical 
lysates and culture medium collected from mycSema3F primary cortical cultures, and in 
addition immunofluorescence on mycSema3F brain sections was performed. The genotype 
of this mouse line was assessed and confirmed by two pairs of primers; the forward and 
reverse primers of the first pair anneal upstream and downstream of the epitope tag 
insertion site, respectively, and they detect both the wild-type and the mycSema3F alleles. 
Thus, this PCR reaction distinguishes among mycSema3F homozygous (myc/mycSema3F), 
heterozygous (myc/+Sema3F) and wild type (Sema3F+/+) mice. The PCR product size for 
the wild type Sema3F allele is 457 base pairs and the size for the mycSema3F allele is 730 
base pairs. The sequences of these primers are: forward primer (anneals upstream of exon 
2): 5’ – tgagccgagggctatgagcatgg – 3’, reverse primer (anneals downstream of exon 2): 5’ 
– tgcagggaaaccagcactgtgagg -3’. The primers of the second pair were used to detect the 
MycSema3F allele only since the forward primer anneals on the epitope tag sequence; 
therefore this PCR distinguishes mice harboring the mycSema3F allele (heterozygous and 
homozygous mice) from wild type mice. The size of this PCR product is 607 base pairs. 
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The sequences of these primers are: forward primer: 5’ – gagagcttgggcgacctcaccatg -3’ 
and reverse primer: 5’-cgatgaattcggcactgggttattaaagtactccgtgg - 3’.  
 
Immunofluorescence 
Tissue processing: brains were dissected out and incubated with Carnoy’s fixative (50ml: 
30ml ethanol, 15ml chloroform, 5ml glacial acetic acid) for 30min until they sink and 
stay at the bottom of the tubes. Fixative was changed and tissue was incubated with 100% 
methanol three times, 30 min. each. Tissue was incubated with Toluene two times, 30 
min. each and at 56ºC for 30min. Tissue was incubated with paraffin two times 30 min. 
each at at 56ºC and then overnight. Tissue was placed in a cassette and embedded in 
molds with paraffin. Embedded brains were stored at room temperature and sectioned 
with a microtome at the sagittal plane, at 10µm thickness.   
Staining: Removal of paraffin and rehydration of the tissue: Xylene 3x 5min. each, 
100% ethanol 3x 3min. each, 95% ethanol 2x 3min. each, 80% ethanol 2x 3min. each, 
ddH2O 5x 1min. each. 0.3% Triton X-100 in PBS, 3x 5min. each. Antigen retrieval: 
10mM sodium citrate, 0.05% Tween-20, pH: 6, boiling for 10min. Then cooling on ice 
for 20min. Blocking: 10% goat serum, 0.1% Triton X-100 in PBS for 1 hour at room 
temperature. Primary antibodies:  Myc (rabbit, Cell Signaling, 71D10) 1:500; Ctip2 
(rat, AbCam) 1:500; CaMKII (mouse, AbCam, cat. no. ab22609). Secondary antibodies: 
Alexa Fluor 488 goat anti-rabbit IgG (Life Technologies), Alexa Fluor 647 goat anti-rat 
IgG (Jackson), Alexa Fluor 546 goat anti-mouse IgG. PBS washes 5x 5min. each. 
Dehydration: 80% ethanol 2x 1min. each, 95% ethanol 2x 1min. each, 100% ethanol 3x 
1min. each.  
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Figure 26. Generation and assessment of the 6xMyc-Sema3F knock-in mouse. 
(A, B) The 6xMyc Sema3F knock-in mouse line was generated by the insertion of a 
6xMyc epitope tag in exon 2 of Sema3F with a two-step recombineering. (A) At the first 
step, which is known as gap repair, the long and short arms were retrieved into the 
backbone vector PBS-DTA, in which short fragments of 500 bp that flanked the locus to 
be retrieved were previously directionally cloned. This retrieval was achieved by 
transforming competent cells containing the Sema3F BAC clone with the linearized PBS-
DTA carrying these 500 bp DNA fragments. This led to the retrieval of the long and short 
arms into the PBS-DTA vector. (B) The mini-targeting vector was constructed with 
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downstream of its signal peptide, and the cloning of floxed NEO cassette about 500 bp 
downstream of exon 2 (intron 2-3: intron between exons 2 and 3). For the 2nd step of 
recombineering, the mini-targeting vector was linearized and then transformed into 
bacterial cells containing the retrieval plasmid obtained from the first step. This second 
recombination led to the generation of the final targeting vector. The latter was linearized 
with Pac I and properly prepared for transformation into embryonic stem (ES) cells. 
Abbreviations and drawings: orange rectangle: 6xMYC epitope tag; LA: long arm, SA: 
short arm, red triangle: loxP site, black vertical lines: restriction sites, MCS: multiple 
cloning site, red horizontal dashed line: long and short arms of the targeting vector. (C, 
D) Testing for germline transmission and genotyping of progeny was performed with two 
different pairs of primers. The forward and reverse primer of the first pair anneal 
upstream and downstream of exon 2, respectively and PCR with this pair gives a WT 
band for the WT allele (457 bp) and the MYC band for the Sema3Fmyc allele (730 bp). 
WT mice should give only the WT band, Sema3Fmyc homozygous mutant mice should 
give only the MYC band, and heterozygous mice give both bands (C). The forward 
primer of the other pair of primers used to genotype this mutant mouse line, anneals on 
the MYC epitope tag while the reverse primer anneals downstream of exon 2. Thus, this 
pair gives a MYC band when the Sema3Fmyc allele id present, regardless of whether the 
mouse is heterozygous or homozygous for the Sema3Fmyc allele, whereas the absence of 
this band shows that this mouse is Sema3F+/+ (D). (E) To test whether the 6xMyc-tagged 
Sema3F protein is expressed and secreted, E14.5 primary cortical neurons were cultured 
from Sema3F+/+ or Sema3Fmyc/myc embryos and incubated in culture for several days. 
Culture medium was collected and concentrated. The concentrated mediums were mixed 
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with Laemmli buffer and samples were analyzed with SDS-PAGE and immunoblotting 
for Sema3F protein using a Myc antibody (clone 9E10, mouse, Sigma). Another Myc 
antibody (rabbit monoclonal, Cell Signaling) gave similar results (data not shown). More 
than one specific bands are seen in the Sema3Fmyc/myc medium, which are not present in 
the Sema3F+/+ medium. Some of these bands might represent cleaved Sema3F (bands 
with a size lower than the predicted).  
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Figure 27. Sema3F protein localization in the mouse brain.  
(A-E’) Sema3F protein expression and localization in the mouse brain was tested on 
brain sections of Sema3FMyc/Myc and Sema3F+/+ mice sacrificed at different 
developmental time points. Brains were processed with organic fixation (Carnoy’s), 
paraffin embedding and staining of microtome-cut brain sections, as described in the 
experimental procedures of this Chapter. Antigen retrieval was also performed to enhance 
immunoreactivity. At P1, strong Sema3F protein expression is detected in the olfactory 
bulbs (central part) (A), the inferior colliculus and a small subset of cerebellar cells (B) 
and the cerebral cortex (C). This signal is specific because it is not detected in the 
Sema3F+/+ brain (A’, B’, C’). At P21, sema3F immunoreactivity in the cerebral cortex is 
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more segregated, compared to P1, in the deeper cortical layers, including Ctip2-positive 
layer V neurons (D, D’). This signal is not detected in the WT brain (E, E’) confirming 
that it is indeed 6xMyc-tagged Sema3F protein.  (F) E14.5 primary cortical neurons were 
cultured from Sema3FMyc/Myc and Sema3F+/+ embryos and stained with Myc, Ctip2 and 
CamKII antibodies. Sema3FMyc/Myc cortical neurons display specific Myc 
immunoreactivity, which represents Sema3F protein, in Ctip2−positive and 
CamKII−positive neurons. Moreover, in some instances, CamKII−positive large 
pyramidal-like neurons in culture are negative for Sema3F, but they are surrounded by 
smaller neurons with strong Sema3F immunoreactivity. These are likely to be inhibitory 























The regulation of distinct aspects of cortical neuron architecture by the Sema3F/Npn-
2/plexinA3 and Sema3A/Npn-1/plexinA4 signaling pathways is a challenging problem to 
elucidate. There are a number of possible mechanisms that mediate the functional 
diversification of these signaling pathways and allow them to affect distinct aspects of 
neuronal morphology and function. First, distinct protein-protein interactions specifically 
involved in either Sema3A or Sema3F signaling, including other transmembrane 
receptors, cytoskeleton regulators, enzymes and cytoplasmic proteins, could generate 
distinct responses to Sema3F and Sema3A. Second, post-translational modifications 
including palmitoylation, differentially affecting Sema3A and Sema3F signaling 
components, could regulate, at least in part, the functional outcome. Third, plexinA3 and 
plexinA4 might propagate the signal by recruiting distinct signaling cascades, therefore 
giving rise to different responses. The same is formally a possibility for Npn-1 and Npn-
2; indeed, a specific signaling component is known to selectively associate with only one 
of the Npns and thereby mediate axon pruning (Riccomagno et al., 2012). Fourth, the 
dendritic localization and local translation of RNA transcripts has emerged as a robust 
mechanism by which proteins achieve their local compartmentalized effects. Further, 
local translation and availability of a protein could make the protein accessible to 
different modifying enzymes or signaling molecules. This possibility is particularly 
tempting for neuropilins, since we have found that both Npn-1 and Npn-2 transcripts are 
localized in the dendrites of primary cortical neurons in vitro by utilizing fluorescent in 
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situ hybridization techniques (FISH) (data not shown). Finally, two or more of the 
aforementioned mechanisms could simultaneously act to convey distinct function to the 
Sema3A and Sema3F signaling pathways.   
 
Does neuropilin palmitoylation convey specificity to semaphorin signaling? 
	
My work shows that both Npn-1 and Npn-2 are robustly palmitoylated in vitro and in 
vivo. Moreover, both neuropilins are palmitoylated in their membrane-proximal 
sequences in a similar pattern. Yet, this modification can be a source of functional 
difference between Npn-1 and Npn-2 by means of the distinct protein interactions Npn-1 
and Npn-2 might have with different palmitoyl acyltransferases (see Chapter 3). 
Palmitoyltransferase substrate specificity has been shown to account for several cases of 
a protein’s functional specificity (Greaves et al., 2010; Mukai et al., 2015; Yanai et al., 
2006) . However, the current work is the first to directly compare two palmitoyl 
substrates that exert distinct functions in the same cell type and to show in DHHC 
knockout neurons, and not in gain-of-function paradigms, that there is strict functional 
segregation within the family of palmitoyl acyltransferases related to their corresponding 
palmitoyl substrates. The mechanism by which DHHC enzymes convey specificity is 
probably the functional interaction among different members of the DHHC protein 
family with distinct cytoskeleton regulators, transmembrane proteins (DHHC enzymes 
are transmembrane proteins) and subsequently with distinct signaling effectors.     
     Another mechanism by which palmitoylation can convey signaling specificity is the 
subcellular location of local palmitoylation events, resulting in a protein being targeted to 
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a particular subcellular compartment (for example, dendritic spines). This requires the 
detection of the palmitoylated fraction of the protein as compared to the localization of 
the total protein. To achieve this, we will need to generate antibodies directed against 
specific palmitoylated forms of palmitoyl substrates (Fukata Y. et al., 2013).  
     In addition, palmitoylation can be regulated by external stimuli (i.e. ligands, neural 
activity). This provides an ideal mechanism for conveying specificity, given that 
particular stimuli can enhance the palmitoylation of a protein at specific subcellular 
compartments and on specific cysteine residues. This stimulus-induced palmitoylation 
specificity is illustrated in the case of Sema3F-induced Npn-2 palmitoylation. In 
particular, Sema3F leads to an increase in Npn-2 palmitoylation but, notably, Sema3A 
does not enhance Npn-2palmitoylation. This selective ligand-induced neuropilin 
palmitoylation is one of the mechanisms by which palmitoylation can convey specificity 
to the neuronal semaphorin signaling, most likely in a two-step process: 1) activation of 
DHHCs specific to one of the two neuropilins and 2) engagement of distinct signaling 
effectors associated with these palmitoyl acyltransferases. Then, two or more 
mechanisms could collaborate to convey functional specificity. However, the 
mechanisms that activate these enzymes have not been elucidated and it is therefore hard 
to provide insight into this question at the present time.  
A dilemma for palmitoylated proteins: are cysteines important as palmitate-
carrying residues or as structural determinants? 
	
My work provides both correlative and causal data supporting the fact that palmitoylation 
of the Npn-2 cysteines is essential for Npn-2 function and that the cysteines themselves 
do not serve as structural determinants of protein dimerization.   
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These data that demonstrate a causal relationship between Npn-2 palmitoylation and 
Npn-2 trafficking and function are: 
1. Inhibition of palmitoylation with 2-bromopalmitate disperses the clusters of Npn-2, 
rendering surface Npn-2 protein diffusely distributed, though all cysteines are still intact. 
2. Cortical neurons lacking specific palmitoyl acyltransferases are incapable of responding 
to secreted Semas and neuropilin palmitoylation in those neurons is significantly reduced.  
The experimental evidence that reveals a strong correlation between Npn-2 
palmitoylation and function is: 
1. Strong correlation between the extent to which a protein is palmitoylated and its rescue 
ability. Specifically, Npn-2 mutants that have severely disrupted palmitoylation have 
completely lost or severely compromised rescue ability, whereas mutants that are still 
quite well palmitoylated rescue the phenotype at least partially.  
2. Sema3F enhances Npn-2 palmitoylation and it is therefore likely that this effect is 
required for sema3F-induced spine constraint.    
Of note, these data supporting the notion that the cysteine residues are functionally 
important because of their palmitoylation does not rule out the possibility that these 
cysteines are also engaged in other intramolecular or intermolecular interactions, for 
instance by forming disulfide bridges. Furthermore, given that palmitoylation is a 
reversible and highly dynamic protein modification, there could be an intricate interplay 
between the palmitoylation of a cysteine residue and its engagement in the formation of 
disulfide bridges. There might be baseline equilibrium between these two processes and 
upon the presence of external stimuli (i.e. Sema3F, electrical activity), and this balance 
could be shifted towards palmitoylation or towards the formation of disulfide bonds.  
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A potential interplay between neuronal activity and semaphorin signaling by means 
of palmitoylation 
	
In neural networks there are at least two main mechanisms that affect circuit assembly: 
chemotropic signaling and neural activity. As stated in the introduction (Chapter 1) 
during neural circuit formation neurons respond to both guidance cues and neuronal 
activity (Greer and Greenberg, 2008; Shen and Cowan, 2010). Therefore, there might be 
a bidirectional interplay between these two processes: on one hand, signaling pathways 
regulate neural development, circuit assembly and synaptic transmission, and on the other 
hand, emerging neuronal activity modulates the response of neurons (by means of the 
receptors expressed on them) to guidance cues. The mechanisms by which neuronal 
activity affects responses to guidance cues are largely unknown. Interestingly, there is 
compelling evidence to show that protein palmitoylation is regulated by activity (Hayashi 
et al., 2009; Kang et al., 2008).  
     Sema3F/Npn-2 signaling is essential for proper formation of excitatory synapses and 
balanced neuronal activity in cortical circuits (Tran et al., 2009). Moreover, the present 
work strongly suggests that palmitoylation of Npn-2 on specific cysteine residues is 
required for the spine constraint caused by Sema3F. It then becomes clear that 
palmitoylation is a post-translational modification critical for regulating synapse 
formation and function in neural circuits. Here, I also show that DHHC15 is involved in 
Npn-2 palmitoylation in cortical neurons. Of note, the DHHC15 homozygous null mutant 
mice are hyperactive (Rebeca Mejias-Estevez, Tao Wang, personal communication), 
which raises the possibility that their neural circuits are hyperexcitable. Although a 
rigorous assessment of the neural activity in the brains of these mice is not available, it is 
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tempting to speculate that these mice exhibit defects similar to the Npn-2-/- mice. This is 
also a striking resemblance to the Sema3F-/- mice, which also display hyperexcitability 
and are prone to seizures (Sahay et al., 2005). This is a behavioral and functional 
similarity that increases the possibility that some of the behavioral deficits of DHHC15 
homozygous mutant mice result in part from the lack of DHHC15-induced Npn-2 
palmitoylation.   
     Thus far, I have described how neuronal protein palmitoylation regulates the 
development of neurons, synapses and neural activity within CNS circuits. What about 
the other side of the coin, namely, that neural activity regulates protein palmitoylation? A 
number of studies have demonstrated that activity regulates the extent to which certain 
proteins are palmitoylated; these proteins include GluR1 and GluR2 (Hayashi et al., 
2005), NR2A and NR2B (Hayashi et al., 2009) and δ-catenin (Brigidi et al., 2014a). In 
the case of δ-catenin, increased synaptic activity upregulates δ-catenin palmitoylation 
mediated by DHHC5, and this leads to an increase in δ-catenin− cadherin association. 
This in turn causes increases in dendritic spine size, synaptic GluA1 and GluA2 and 
postsynaptic currents. (Brigidi et al., 2014a). In other words, activity alters protein 
palmitoylation, which in turn modulates synaptic function. 
     I have previously shown that activity alters Npn-2 palmitoylation levels. Moreover, 
treatment of neurons with bicuculline (which increases neural activity) leads to a 
significant increase in Sema3F secretion (Qiang Wang, Chapter 4). Here, I show that 
Sema3F enhances Npn-2 palmitoylation and therefore leads to a more robust Npn-2 
function. This suggests the existence of a negative feedback loop whereby excessive or 
unnecessary increases in network activity enhances Sema3F secretion, and this in turn 
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upregulates Npn-2 palmitoylation, thereby enhancing Npn-2’s excitatory synapse-
restricting function in order to compensate for the increased activity and to maintain the 




In summary, we have discovered that the post-translational modification palmitoylation 
occurs on neuropilins and that this modification is critical for neuropilin protein 
subcellular distribution and function in cortical neurons. This is particularly important 
since palmitoylation is reversible and it therefore has the potential to dynamically 
regulate protein trafficking and function. This raises the intriguing possibility that 
external stimuli (i.e. Sema3F, Sema3A, neural activity, neurotransmitters) modulate 
neuropilin function by altering its palmitoylation status. Given that some of these stimuli 
are directly related to the external environment where a living organism is exposed (for 
instance neural activity), neuropilin palmitoylation could mediate some of the molecular 
responses (structural rearrangements of dendritic spines and arbors) of context-related 
stimuli. Furthermore, we have found that palmitoylation conveys specificity to the class 3 
secreted semaphorin signaling pathways by means of palmitoyltransferase substrate 
specificity. This modification can therefore explain, at least to some extent, the functional 
divergence and specification of Npn-1 and Npn-2, and by extension, Sema3A and 
Sema3F. This finding has broader implications for all palmitoyl substrates, which by 
means of palmitoylation can achieve a great degree of functional specificity in time 
(during development), space (subcellular compartment) and distinct neurodevelopmental 
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processes (axon pathfinding, dendritic arborization, dendritic spine formation and/or 
maintenance, synaptic plasticity, embryonic and adult neurogenesis). Moreover, the 
implication of protein palmitoylation in a multitude of neuronal physiological processes 
makes it likely that is also plays essential roles in the pathogenesis of diseases of the 
CNS, including neurodegenerative and cognitive disorders. This is supported by the 
discovery of genetic defects of various palmitoyltransferases in humans with cognitive 
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